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A longstanding debate within the field of psychological assessment centers on whether 
personality disorders (PDs) are better classified by categorical (i.e., syndrome) or dimensional 
models.  In fact, the most recent version of the Diagnostic and Statistical Manual for Mental 
Disorders (DSM-5) includes an optional, dimensional model, the Alternative Model for 
Personality Disorders (AMPD).  The current studies examined the underlying factor structure of 
the MMPI-2 PD Spectra Scales developed by Mulay et al. (2018) to determine whether the 
Scales were more reflective of a dimensional or categorical model for PDs.  Study 1 consisted of 
exploratory factor and bifactor analyses of the entire Spectra Scales item pool (220 items), tested 
on a sample of 1,030 outpatients seen at a university community clinic.  Results supported an 
exploratory factor model made up of six factors and an exploratory bifactor model made up of a 
general factor and five specific factors, both of which were fit to a 53-item subset of the original 
220 PD Spectra Scales items following item deletion procedures.  Study 2 sought to confirm the 
factor structures resulting from the Study 1 analyses using confirmatory factor and confirmatory 
bifactor analyses.  Criterion validity (based on MCMI-II Clinical Scales) and reliability analyses 
of the final bifactor model were also completed in Study 2.  Participants were 539 inpatients and 
outpatients seen at a military clinic.  Results supported the bifactor model over the factor model.  
The final bifactor model demonstrated good criterion validity and excellent internal consistency 
for the model as a whole.  The bifactor model is interpreted in the context of preexisting 
dimensional models for PDs, and potential clinical utility and recommendations for future 
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CHAPTER ONE: INTRODUCTION AND GENERAL INFORMATION 
It is estimated that approximately 10% of individuals in the general U.S. population 
(Paris, 2015) and 40% of individuals in community health patient populations (Newton-Howes et 
al., 2010) meet criteria for a personality disorder (PD).  Not only are PDs highly prevalent, but 
treatment can prove costly.  For example, the cost of treatment as usual for an individual 
diagnosed with borderline personality disorder (BPD) has been estimated at $52,563 annually 
(Bateman & Fonagy, 2003).   
 The prevalence rates for PDs are substantially influenced by diagnostic factors.  PD 
diagnostic criteria have gone through a number of revisions since the publication of the first 
edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM; American 
Psychiatric Association, 1952).  Despite changes to the specific criteria for PDs, all published 
versions of the DSM have retained the description of PDs as the inflexible over-application of 
personality traits across contexts, to the detriment of the individual’s interpersonal relationships 
and overall functioning.  The same has been true for the International Statistical Classification of 
Diseases and Health Related Problems (ICD), Psychodynamic Diagnostic Manual (PDM), and 
psychodynamic and psychobiological conceptualizations of PD.   
 For decades, clinical psychologists have debated whether to continue to utilize 
categorical modeling of PD criteria or to shift toward a dimensional model.  This debate has 
come to a head with the inclusion in the current version of the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-5; American Psychiatric Association, 2013) of an alternative model 
for diagnosing PDs that is dimensional in nature.  As most preexisting PD measurement 
instruments follow the categorical model for PDs, the introduction of a formalized dimensional 




current studies were conducted based on a set of PD Spectra scales developed from preexisting 
Minnesota Multiphasic Personality Inventory, second edition (MMPI-2; Butcher et al., 2001) 
items by Mulay and colleagues (2018), and examined whether the underlying factor structure of 





CHAPTER TWO: LITERATURE REVIEW 
A Brief History of the Conceptualization of PDs 
In 192 AD, Galen attributed aspects of character pathology to the Hippocratic theory of 
four primary humours: chole (bile), melanchole (black bile), sanguis (blood), and flegma 
(phlegm; Stelmack & Stalikas, 1991).  Aside from one optimal temperament, defined by a 
perfect balance between the two humourous axes of cold-hot and moist-dry, Galen identified 
eight undesirable temperaments based on an excess of any of the four poles or two poles in 
excess at once.  Although Galen was fragmentary in his explanation of the aspects of character 
that related to each of the eight undesirable temperaments, his conceptualization is the earliest 
known mention of what is now termed personality pathology.  
 Nicholas Culpeper was the next theorist to expand upon Galen’s theory, when in 1652 he 
elaborated on the character descriptions for each of Galen’s temperaments (Stelmack & Stalikas, 
1991).  In the 18th century, Immanuel Kant and Wilhelm Wundt elaborated further upon the 
theory, when each conceptualized temperament as psychological in nature and composed of two 
axes (feeling-activity and strength of emotions-changeability).  Thomas Octavius Prichard was 
arguably the first theorist to introduce a conceptualization of personality pathology that is 
somewhat commensurate with current PD conceptualization; in 1837, he used the term moral 
insanity to describe a disorder characterized by disturbance in social functioning but absent of 
impaired mental status (Livesley, Schroeder, Jackson, & Jang, 1994).  Prichard’s work marked 
the beginning of the understanding of PDs as separate from mental state disorders.  In the 18th 
and 19th centuries, Philippe Pinel, Bénédict Augustin Morel, and Emil Kraepelin took a more 
biological stance when they theorized that personality pathology was caused by 




their contemporary, Julius Koch argued that mental state disorders and PDs were distinct with 
his introduction of the term psychopathic (Livesley et al., 1994).  Koch’s work set the stage for 
the first formal classification of PDs. 
 In 1923, PDs were formally classified when Kurt Schneider described nine personality 
types, which he then termed psychopathic personalities (Tyrer et al., 2015).  Schneider’s 
psychopathic personalities were informed by his clinical experiences, and many aspects of his 
classification system are reflected in the categorical conceptualizations of PDs found in the 
International Classification of Diseases (ICD, since version 6) and the Diagnostic and Statistical 
Manual for Mental Disorders (DSM, all editions). Schneider wrote, “Those with personality 
disorders suffer because of their disorders and also cause society to suffer” (1923), a description 
that echoes the core of current PD conceptualization: the inability to form and maintain 
satisfactory relationships.  Then, in 1925, Ernst Kretschmer postulated that mental state disorders 
and PDs exist on a continuum ranging from schizothyme to schizoid to schizophrenic (Livesley 
et al., 1994).  Today, debate continues around whether PDs are a discrete class of disorders and 
how to most accurately conceptualize PDs.  However, both categorical classification of PDs and 
the idea that PDs fundamentally differ from mental state disorders have largely been retained in 
formal classification systems (e.g., DSM, ICD, PDM).  The following review of categorical 
classification systems will be limited to the DSM because its most current edition (DSM-5; 
American Psychiatric Association, 2013) includes the first formal, albeit tentative, dimensional 
model for PDs. 
Categorical Modeling of PDs in the DSM 
 The DSM has traditionally presented PD criteria using a categorical, or syndrome, model.  




to stem from a common cause (i.e., the syndrome in question; Zapolski, Guller, & Smith, 2012).  
Criteria often include heterogeneous symptoms, and individuals who meet criteria for the 
syndrome may not have the same symptoms (Zapolski et al., 2012).  The presentation of 
categorical PDs in each version of the DSM is described below. 
 The first version of the DSM described PD as “those cases in which the personality 
utilizes primarily a pattern of action or behavior in its adjustment struggle, rather than symptoms 
in the mental, somatic, or emotional spheres” (American Psychiatric Association, 1952, p. 13).  
PDs were further described as generally lifelong, treatment resistant, and ego dystonic.  DSM-I 
categorized 12 specific PDs into three groups, as follows: personality pattern disturbance 
(inadequate, schizoid, cyclothymic, and paranoid personality), personality trait disturbance 
(emotionally unavailable, passive-aggressive, and compulsive personality; personality trait 
disturbance, other), and sociopathic personality disturbance (antisocial, dyssocial [sic], and 
sexual deviation; addiction).  Personality pattern disturbances involved the highest levels of 
impairment and were considered the most deep-seated, whereas those diagnosed with personality 
trait and sociopathic personality disturbances were generally higher functioning but could regress 
to a lower level of functioning under stress.  A fourth group, special symptom reactions, was 
included “for flexibility in diagnosis” (American Psychiatric Association, 1952, p. 34) and 
allowed clinicians to specify a symptom thought to be caused by PD that was not included 
elsewhere in the diagnostic scheme (e.g., enuresis).   
 DSM-II (American Psychiatric Association, 1969) again described PDs as lifelong, 
ingrained maladaptive patterns of behavior.  However, the classification system for PDs was 
revised to include 10 specific PDs (paranoid, cyclothymic, schizoid, explosive, obsessive 




“other” PD and “unspecified” PD.  A lack of diagnostic reliability observed with the DSM-I and 
DSM-II criteria inspired a more concrete approach to classifying PDs in DSM-III (Widiger, 
Livesley, & Clark, 2009). 
 The third version of the DSM (DSM-III; American Psychiatric Association, 1980) was the 
first to include the multiaxial diagnostic system, wherein Axis II was devoted to PDs and specific 
developmental disorders, because these were conceptualized as more stable than the Axis I 
disorders.  The diagnostic section on PDs delineated the differences between personality traits 
and PDs and mentioned the high prevalence of depression and anxiety symptoms in individuals 
with PDs.  Whereas previous versions instructed clinicians to choose the “most prominent” PD 
when criteria for more than one PD were met, DSM-III stated that multiple PDs often co-occur in 
the same person.  The 11 specific PDs included in DSM-III were: paranoid, schizoid, schizotypal, 
histrionic, narcissistic, antisocial, borderline, avoidant, dependent, compulsive, and passive-
aggressive.  Notably, patients were required to exhibit all symptoms of a PD in order to meet 
criteria for diagnosis.  This choice to pursue a clinical syndrome model was an attempt to 
develop homogenous diagnostic units (Widiger et al., 2009; see the next section for more 
discussion of the heterogeneity of other categorical models of PD).  PD presentations that did not 
fit the specific PD categories could be diagnosed under atypical (PD is thought to be present, but 
there is insufficient information available), mixed (features of more than one PD are present, but 
full criteria is not met for any PD), or other (a specific PD not included in the classification 
scheme) PD.   
 The DSM-III-R (American Psychiatric Association, 1987) largely retained the PD criteria 
from DSM-III, but categorized PDs into three formal clusters (Cluster A: eccentric, Cluster B: 




was renamed obsessive-compulsive PD in this DSM version.  Also, because many individuals 
who clearly displayed PD pathology did not meet criteria for the DSM-III categorical PDs due to 
the requirement of homogenous symptom presentation, this diagnostic model was not retained.  
Instead, a polythetic criterion set model was instated, wherein individuals must exhibit a certain 
number of the possible symptoms in order to meet criteria for the disorder in question.  This was 
in essence a surrender to the heterogeneity of categorical modeling of PDs (Widiger et al., 2009) 
and constituted a “neo-Kraepelin” movement away from psychosocial and psychodynamic 
viewpoints.  In other words, the polythetic criterion set model was supported and instated by 
psychologists who generally opposed the psychodynamic approach, championed the importance 
of classification, and were highly interested in research (Blashfield, 1984).  The change was also 
made in an attempt to increase inter-clinician reliability of PD diagnosis, yet DSM-III/DSM-III-R 
PD classification performed poorly in this area (Blashfield, 1984). 
 The fourth version of the DSM (DSM-IV; American Psychiatric Association, 1994) 
dropped passive-aggressive PD, but retained the other 10 DSM-III-TR specific PDs.  
Additionally, the DSM-III/DSM-III-R options for diagnosing PD when (1) criteria were not fully 
met for a specific PD or (2) a specific PD other than the 10 listed was present were collapsed 
under the diagnosis of PD not otherwise specified (PD-NOS).  Mention of childhood disorders 
that could result in later PDs was also dropped.  Notably, mention was made in DSM-IV that a 
dimensional model for PDs may be warranted, but the manual fell short of supporting any such 
models and stated, “the relationship of the various [potential] dimensional models to the 
Personality Disorder diagnostic categories...remains under active investigation” (American 
Psychiatric Association, 1994, p. 634).  The text revision of the fourth edition (DSM-IV-TR; 




current version of the DSM (DSM-5; American Psychiatric Association, 2013) retained the DSM-
IV/DSM-IV-TR criteria for PDs for Section II (Diagnostic Criteria and Codes), but added an 
optional, alternative PD conceptualization in Section III (Emerging Measures and Models).1  The 
DSM-5 Section III model is discussed in the next section.  Notably, DSM-5 did away with the 
multiaxial diagnostic metastructure, in an attempt to stop insurance companies from denying 
coverage of Axis II disorders and as a nod to the potential instability of PDs (see next subsection 
for more information; Wakefield, 2013). 
 Thus, there is an extensive, and nearly exclusive, tradition of modeling PDs categorically 
in the clinical psychological sciences.  Categorical modeling of PDs theoretically allows for 
simpler diagnostics and provides a straightforward way of communicating patients’ clinical 
presentations and symptomology to other providers.  However, there is a plethora of literature 
detailing the disadvantages of categorical modeling of PDs that suggests the costs of retaining a 
categorical conceptualization of PDs may outweigh the benefits of this approach. 
Criticisms of the Categorical Model for PDs 
 Over the last century, researchers and theoreticians have called into question the validity 
and utility of a categorical conceptualization of PDs (e.g., Schneider, 1923; Livesley et al., 1994; 
Millon, 1994; Widiger & Trull, 2007; Widiger et al., 2009; Kotov et al., 2017). The most 
common criticisms of the categorical model for PDs are (1) the problem of comorbidity with 
Axis I disorders and multiple PDs, (2) poor temporal stability of diagnostic presentations, (3) 
potential gender bias in certain specific PD criteria, and (4) insufficient descriptive utility 
reflected in specific PD criteria.  Each criticism is explained further below. 
                                                 




 Comorbidity. Recent research examining comorbidity between PDs and what were 
previously known as Axis I disorders find clinical sample comorbidity rates ranging from 22-
89% (Friborg, Martinussen, Kaiser, Øvergård, & Rosenvinge, 2013; Newton-Howes et al., 2010; 
Pagura et al., 2010; Sjåstad, Gråwe, & Egeland, 2012; Verheul & Widiger, 2004; Wetterborg, 
Långström, Andersson, & Enebrink, 2015).  Anxiety and depressive disorders are most 
commonly comorbid with PDs (Erkens et al., 2018), but comorbidity with PTSD (Pagura et al., 
2010), substance use disorders (Hasin, Stinson, Ogburn, & Grant, 2007) and eating disorders 
(Ramklint, Jeansson, Holmgren, & Ghaderi, 2010) is also common in clinical populations.  Some 
have argued that comorbidity rates may be inflated when assessment method and timing of 
assessment are not taken into account (Clark, 2006; Ramklint et al., 2010).  However, a recent 
study found a comorbidity rate of 37% for eating disorders and PD in a female clinical 
population, even after controlling for assessment method and timing of assessment (Ramklint et 
al., 2010).  Furthermore, certain personality traits (e.g., neuroticism, disinhibition) and latent 
transdiagnostic features (i.e., internalizing-externalizing) have been shown to account for much 
of observed comorbidity patterns (Krueger & Markon, 2006; Rodriguez-Seijas, Eaton, & 
Krueger, 2015), indicating personality is implicated in psychopathology. 
 Comorbidity amongst PDs is also a common issue in PD diagnosis.  A study of PD 
comorbidity using DSM-III-TR criteria found that 48% of participants met criteria for more than 
one PD (Ekselius, Lindström, von Knorring, Bodlund, & Kullgren, 1994).  Another study 
compared Axis II comorbidity rates of a clinical sample of individuals diagnosed with borderline 
PD (BPD) to a clinical sample of individuals who met criteria for another PD using DSM-III-TR 
PD criteria (Zanarini et al., 1998).  Results showed that, in the BPD group, 31.4% also met 




criteria for another dramatic cluster PD.  In the other PD group, 10.4% also met criteria for an 
odd cluster PD, 47.2% met criteria for an anxious cluster PD, and 30.4% met criteria for a 
dramatic cluster PD.  These results illustrate the lack of specificity of categorical PDs, which is 
elaborated upon further below (see the “descriptive utility” subsection).  In addition, the findings 
point to a particular lack of specificity for BPD, a common criticism of the disorder that has led 
to arguments that BPD may actually measure general distress in interpersonal functioning and 
identity instability rather than qualifying as a specific PD (Sharp et al., 2015).  
 Temporal instability. PD has been described in all versions of the DSM as enduring and 
stable, even with psychological treatment.  However, research findings from major studies have 
called into question the stability of PDs.  For example, the Collaborative Longitudinal 
Personality Disorders Study (CLPS) reported significant changes in PD symptomology over a 
two-year period in a mixed in- and outpatient population, and found no significant treatment 
effects (Grilo et al., 2004; Shea et al., 2002).  One year after initial assessment, 20% of 
participants had met less than two PD criteria throughout the past year, with remission rates 
ranging from 20-40% at year two.  Even more strikingly, only 44% of participants met criteria 
for a PD every month during year one.   
 A number of other studies have also found evidence for temporal instability in categorical 
PDs.  All accounted for potential treatment effects.  Durbin and Klein (2006) found poor to fair 
stability of categorical PD diagnoses in a clinical population over 10 years.  Lenzenweger, 
Johnson, and Willett (2004) found statistically significant variation in PD features in an 
undergraduate population over a four year period using growth curve analysis.  Zanarini and 
colleagues (2005) observed remission of BPD in 74% of a clinical sample after six years.  




interviewers may have over-applied normative standards when they judged whether particular 
traits were stable and enduring, such that the reported levels of PD stability were underestimated 
because PD symptoms were wrongly judged to be normative personality traits (Clark, 2006).  
Notably, results of the CLPS showed that PD dysfunction was more stable than PD traits (Skodol 
et al., 2005; Tyrer, Seivewright, & Johnson, 2004), which is supportive of efforts to focus PD 
conceptualization on dysfunction rather than abnormality (see the following section on 
dimensional modeling of PDs for elaboration). 
 Gender bias. The concern that existing PD criteria may unfairly characterize 
stereotypically feminine or masculine characteristics as pathological is another much echoed 
criticism of the categorical model for PDs (Clark, 2006).  One way of testing gender bias 
involves comparing men and women’s self-reports of PD symptomology.  Item analyses of 
DSM-IV-TR PD criteria revealed moderate gender biased responding to three antisocial PD 
criteria (biased toward men), one paranoid PD criterion (biased toward men), and two schizoid 
PD criteria (biased toward women; Jane, Oltmanns, South, & Turkheimer, 2007).  Narcissistic 
(Lindsay & Widiger, 1995) and borderline (Hoertel, Peyre, Wall, Limosin, & Blanco, 2014) PD 
criteria have also been critiqued for containing gender bias.  However, studies of gender bias in 
PD criteria at the disorder level have found little to no overall effect on diagnosis (K. G. 
Anderson, Sankis, & Widiger, 2001; Morey, Warner, & Boggs, 2002).  Still, perceived gender 
stereotypes for PDs (e.g., antisocial as masculine and histrionic as feminine) have been shown to 
have societal implications, such as increased stigmatization (Boysen, Ebersole, Casner, & 
Coston, 2014).   
 It is also possible that clinicians show gender bias when they diagnose PD, regardless of 




topic, one study found that clinicians were more likely to diagnose borderline PD in women and 
narcissistic PD in men when given case presentations that were identical except for the patient’s 
gender (Braamhorst et al., 2015).  Widiger (2000) posited that a move toward gender-neutral 
criteria--rather than, for example, “feminizing” antisocial PD and “masculinizing” dependent 
PD--is the best approach to correcting potential gender biases in conceptualizations and clinician 
applications of PD criteria.   
 Descriptive utility. A meta-analysis of PD not otherwise specified (PD-NOS, or other 
specified personality disorder [OSPD] in DSM-5) found that the disorder is diagnosed in 8-13% 
of patient samples, and makes up 21-49% of all PD diagnoses (Verheul & Widiger, 2004).  
Verheul and Widiger (2004) proposed that either (1) individuals diagnosed with PD-NOS do not 
have enough symptoms to meet the specific PD criteria cutoffs or (2) “the complexity of 
personality pathology seen clinically is difficult to categorize...with our current DSM system” (p. 
907).  Other researchers have echoed these critiques (Clark, 2006 offers a review; see Vinnars & 
Barber, 2008 for a case study).  In fact, attempts to categorically model any form of 
psychopathology inevitably result in a loss of specificity (Zapolski et al., 2012).  Categorical PDs 
specifically have been criticized for providing a collection of heterogeneous maladaptive 
personality traits, wherein two individuals can meet criteria for the same PD but not share any 
symptoms in common (Widiger et al., 2009; Widiger & Trull, 2007).   
 Additionally, Verheul and Widiger (2004) found no significant differences in 
psychosocial functioning and suicide attempts or behaviors between those diagnosed with PD-
NOS and specific PDs.  This suggests that PD-NOS is not a “lesser” diagnosis in terms of 
impairment.  All of these criticisms constitute a clear lack of descriptive utility and specificity in 




communication between providers and inform treatment planning (see Mullins-Sweatt & 
Widiger, 2009 for their useful operationalization of clinical utility).  
Paradigm Shift: From Categorical to Dimensional Modeling of PDs 
 In contrast to a categorical model, a dimensional model for psychiatric disorder involves 
rating individuals based on homogeneous dimensions (Zapolski et al., 2012).  In the case of PDs, 
a dimensional model is composed of a rating system for an individual’s severity levels on 
multiple dimensions of personality (Zapolski et al., 2012).  Benefits of the dimensional approach 
include (1) clearer meaning of disorder dimensions, (2) opportunities to validate the dimensions, 
and (3) clearer descriptions of patients (Eaton, Krueger, South, Simms, & Clark, 2011; Zapolski 
et al., 2012).  Additionally, dimensional models of PD allow for integration of the normal and 
abnormal models of personality description and thereby characterize PDs as maladaptive variants 
of the personality characteristics of all individuals (which could positively affect the stigma 
surrounding the disorders; Widiger et al., 2009).  Because PDs are variable and complex in their 
presentation, sensitive to and sometimes reflective of cultural and social values, and etiologically 
diverse, the nuance inherent in dimensional modeling grants it the potential for being a preferred 
mode of PD classification (Kendler, 2012; Kendler, Zachar, & Craver, 2011).  Furthermore, the 
implementation of a dimensional model for PDs may mitigate many of the criticisms of the 
existing categorical model described above. 
 The push to move from a categorical to a dimensional model for PDs is not new.  Allen 
Frances, chair of the DSM-IV Task Force, conceded 26 years ago that a dimensional model for 
PDs was “not whether, but when and which” (Frances, 1993, p. 110).  Clark (2006) reviewed 
relevant PD assessment and diagnostic systems and called for a dimensional model that included 




pathology experts have similarly argued for a shift to a dimensional model (a small sampling: 
Livesley et al., 1994; Millon, 1994; Livesley, 1998; Widiger & Trull, 2007; Widiger et al., 2009; 
Kendler et al., 2011; Kendler, 2012; Krueger, Derringer, Markon, Watson, & Skodol, 2012).  
However, the DSM-5 is the first edition of the DSM to include a dimensional-hybrid model for 
PDs.  The model is included in Section III and titled “The Alternative DSM-5 Model for 
Personality Disorders” (AMPD).  In the AMPD, individuals are first rated dimensionally on 
personality functioning and identity development and then assigned specific, maladaptive 
personality traits.  The Section III model does away with the PD-NOS/OSPD diagnosis and 
allows for a detailed description of the specific traits of individuals who meet criteria for PD.  
Diagnoses of six specific PDs are included, along with a diagnosis of personality disorder-trait 
specified (PD-TS) for presentations that do not fit any of the specific disorders.   
 Criterion A, level of personality functioning, requires clinicians to rate the patient’s level 
of impairment in two domains: self (broken up into identity and self-direction dimensions) and 
interpersonal (empathy and intimacy dimensions).  Ratings range from 0 (little or no impairment) 
to 4 (extreme impairment).  Criterion B is made up of 25 pathological personality traits that are 
organized into five categories: negative affectivity, detachment, antagonism, disinhibition, and 
psychoticism.  These categories represent maladaptive variants of the Five Factor Model of 
Personality2, and are closely linked to the domains of the Personality Psychopathology Five 
scales (PSY-5; American Psychiatric Association, 2013).  Criteria C and D require that the 
impairments in personality functioning and pathological personality traits be relatively pervasive 
                                                 
2
 The Five Factor Model (FFM; McCrae & Costa, 1987) is the most widely studied and agreed upon model of 
personality.  The model’s five personality dimensions of neuroticism, extraversion, openness, agreeableness, and 




and stable.  Criteria E, F, and G require that clinicians consider potential differential diagnoses 
before making a PD diagnosis. 
 The specific PDs included in the AMPD are antisocial, avoidant, borderline, narcissistic, 
obsessive-compulsive, and schizotypal.  Each is described qualitatively and then disorder criteria 
are listed.  The diagnoses all require moderate or greater impairment in personality functioning 
(Criterion A) and a collection of pathological personality traits (Criterion B).  The remaining 
Section II-specific PDs of paranoid, schizoid, histrionic, and dependent “are represented also by 
the diagnosis of PD-TS...and can be specified by the relevant pathological personality trait 
combinations” (American Psychiatric Association, 2013, p. 771), but they are not mentioned 
overtly in the AMPD.  The specific PDs were chosen based on empirical data on prevalence, 
level of impairment, and diagnostic uniqueness from other PDs (American Psychiatric 
Association, 2013). 
 Notably, although some members of the DSM-5 Task Force on PDs argued for the 
replacement of the categorical model for PDs with the AMPD in the main section of DSM-5 
(Zachar, Krueger, & Kendler, 2016), both the Section II and Section III models for PDs were 
included in the final version.  This was reportedly done “to preserve continuity with current 
clinical practice, while also introducing a new approach that aims to address numerous 
shortcomings of the current approach to personality disorders” (American Psychiatric 
Association, 2013, p. 761).  The Personality Inventory for the DSM-5 (PID-5; Krueger et al., 
2012) was developed based on the AMPD and has provided a standardized method for testing 
the dimensional conceptualization of PD.  Research to date has supported the psychometric 
properties of the PID-5 and therefore the AMPD (Crego & Widiger, 2016; Finn, Arbisi, Erbes, 




(2014) tested correlations between SCID-II (First, 1997) PD scales and those of the PID-5 
(Krueger, Derringer, Markon, Watson, & Skodol, 2013) to examine validity of the AMPD.  
Results supported global convergent and divergent validity for the new model.   
 Research has also supported the clinical utility of the AMPD.  Fowler and colleagues 
(2018) found that the PID-5 displayed adequate specificity and sensitivity as a screening tool for 
BPD.  Morey, Skodol, and Oldham (2014) asked clinicians to perform PD assessments on their 
patients using both the DSM-IV-TR and AMPD criteria and then evaluate the clinical utility of 
each model.  Although some clinicians have expressed resistance to learning a new classification 
system for PDs, Morey et al. found that clinicians rated the AMPD as equally or more useful 
than DSM-IV-TR in all areas tested (i.e., professional communication, comprehensiveness, 
descriptiveness, ease of use, communication with patients, and utility for treatment planning; 
also, see Waugh et al., 2017 for a review of the AMPD’s clinical utility and validity).  
Furthermore, as Kotov et al. (2017) pointed out, dimensional measurements (e.g., MMPI, PAI) 
have been frequently used in clinical contexts for decades and dimensional models for other 
psychological disorders (e.g., intellectual disabilities, autism spectrum disorders) are already in 
place.   
 A number of PD measurement instruments exist, most of which have been based on 
categorical modeling of PDs (i.e., the Millon scales, SWAP, PAI).  However, there may be 
opportunities to adapt these preexisting PD measures to reflect a more dimensional 
conceptualization of PD, rather than creating completely new versions of measures.  The 
Minnesota Multiphasic Personality Inventory, second edition (MMPI-2; Butcher et al., 2001) is 




History of the Minnesota Multiphasic Personality Inventory 
 The first version of the Minnesota Multiphasic Personality Inventory (MMPI; Hathaway 
& McKinley, 1942) was developed in 1940 by Starke R. Hathaway, a clinical psychologist, and 
J. Charnley McKinley, a neuropsychiatrist.  Their intention was to create an omnibus measure of 
psychopathology that would provide a broader, more structured array of personality descriptions 
(Hathaway & McKinley, 1942; Meehl, 1945).  The MMPI was developed using the empirical 
approach to scale construction, wherein scale items were based on differential responding 
between those diagnosed with the disorder in question and “normals” (Drayton, 2009).  In other 
words, scale items were decided upon based on clinical prevalence, rather than by clinicians’ 
judgments of what a particular disorder or trait should “look like” on a questionnaire.  By the late 
1950s, the MMPI had become the most widely used objective measure of psychopathology and 
personality (Dahlstrom, 1992). 
 Calls to revise the MMPI grew loud by the 1970s, as items were criticized for being 
outdated and the original norms were no longer representative of the U.S. population (University 
of Minnesota Press, 2011).  A committee was formed at the University of Minnesota to re-
standardize the test, while maintaining as much of the original structure as possible (University 
of Minnesota Press, 2011).  This re-standardized version, The Minnesota Multiphasic Personality 
Inventory, second edition (MMPI-2; Hathaway, 1989) was published in 1989.  The MMPI-2 was 
validated on a sample of 2,600 adults, and there are over 10,000 published manuscripts on 
research using the instrument (Drayton, 2009).   
 The MMPI-2 was revised in 2008, spurred by criticism that the MMPI-2 was useful for 
determining whether psychopathology was present but poor at measuring the content of the 




items, resulting in the reduced (388 items) MMPI-2-Restructured Form (MMPI-2-RF; Ben-
Porath, 2008).  The factor analysis was first used to determine a general demoralization score 
(RCd/Demoralization), and items that loaded heavily onto RCd were removed from the clinical 
scales.  The clinical scales were then refined further, resulting in a set of Restructured Clinical 
(RC) scales.  Another addition to the MMPI-2-RF was the Personality Psychopathology Five 
(PSY-5) scales; these were developed through work with a group of laypeople on the 
development of five easily understandable, distinctive, and relevant personality constructs 
(Groth-Marnat, 2009).  Because it is a condensed version of the MMPI-2, the MMPI-2-RF can 
be scored from a MMPI-2 administration.  Therefore, the RC and PSY-5 scales are now 
available for the MMPI-2. 
 Despite their vast clinical utility, all existing versions of the MMPI lack distinct 
personality disorder diagnostic scales.  Such scales are of great potential use for clinicians, 
especially given the relative difficulty of diagnosing PDs.  The following subsection describes 
past attempts to develop PD scales for the MMPI. 
PD Scale Development for the MMPI/MMPI-2 
 Several attempts have been made to develop sound PD scales using existing 
MMPI/MMPI-2 items (i.e., Morey, Waugh, & Blashfield, 1985; Raskin & Novacek, 1989; Wink 
& Gough, 1990; Levitt & Gotts, 1995; Somwaru & Ben-Porath, 1995; Mulay et al., 2018).  
These scales and their psychometric properties are described below.  The final scales described, 
Mulay et al.’s (2018) PD Spectra scales, are the focus of the current studies. 
 Morey, Waugh, and Blashfield (1985) published the first set of PD scales for the MMPI, 
based on DSM-III (American Psychiatric Association, 1980) criteria for PDs.  They employed a 




reviewed the MMPI for items representative of the PD criteria.  Then, the scale items were 
narrowed down by iterative empirical item-analyses and final scales were tested through 
correlational analyses.  The final result was 11 PD scales: paranoid, schizoid, borderline, 
compulsive, passive-aggressive, narcissistic, antisocial, histrionic, schizotypal, dependent, and 
avoidant.  Intercorrelations between the scales mirrored expected relationships based on DSM-III 
PD criteria.  A follow up study supported external validity of the scales by comparing responses 
between controls and individuals diagnosed with PDs.  However, as Morey et al. (1988) stated, 
“the difficulty in identifying rigorously defined criterion groups in personality disorder makes all 
diagnostic validation research in this area somewhat preliminary” (p. 50). 
 Due to the release of new versions of the DSM and MMPI, Somwaru and Ben-Porath 
(1995) developed an alternative set of PD scales (11 scales: antisocial, avoidant, borderline, 
dependent, histrionic, narcissistic, obsessive compulsive, paranoid, schizoid, schizotypal).  The 
scales were made up of items from the MMPI-2 (Hathaway, 1989) and used DSM-IV (American 
Psychiatric Association, 1994) PD criteria as a guide.  Subsequent study of the scales’ construct 
validity showed similar patterns of validity to the Morey et al. (1985) scales.  Additionally, items 
on the Somwaru and Ben-Porath (1995) schizoid, antisocial, and borderline PD scales 
demonstrated higher correlations with corresponding scales on other PD measures (i.e., PDQ-4; 
Hyler, 1994; and MCMI-III; Millon, Millon, & Davis, 1994) compared to the Morey et al. (1985) 
scales.   
 In an attempt to update and validate the work of Morey et al. (1985), Levitt and Gotts 
(1995) used the DSM-III-R (American Psychiatric Association, 1987) criteria to mine the MMPI 
and MMPI-2 to develop yet another updated set of 11 PD scales (paranoid, schizoid, borderline, 




avoidant).  Jones (2005) compared the incremental validity of the Levitt and Gotts (1995) scales 
to that of the Morey et al. (1985) and Somwaru and Ben-Porath (1995) scales.  After comparing 
all three scale sets to the MCMI-II (Millon, Millon, & Davis, 1987), results showed that the 
Levitt and Gotts (1995) and Somwaru and Ben-Porath (1995) scales arguably demonstrated 
incremental validity over the Morey et al. (1985) scales.  Additionally, the Somwaru and Ben-
Porath (1995) scales demonstrated the best internal consistency overall, with all scale alphas 
ranging from good to excellent.  However, the attenuation paradox (i.e., when redundancy of 
item content inflates scale reliability to the detriment of its validity; Loevinger, 1954) and 
overreliance on alpha statistics (Streiner, 2003) call the conclusions that accompanied these 
findings into question.   
 Additional efforts have been made to develop narcissism scales from MMPI items.  
Raskin and Novacek (1989) developed one narcissism scale by correlating undergraduate 
participants’ responses on the Narcissistic Personality Inventory (NPI; Raskin & Hall, 1979) 
with MMPI response items.  The scale items converged with the Morey et al. (1985) narcissism 
scale.  Wink and Gough (1990) also created an MMPI narcissism scale, using DSM-III 
(American Psychiatric Association, 1980) criteria.  This scale, too, correlated as expected with 
the NPI and the Morey et al. (1985) narcissism scale.  However, conceptualizations of 
narcissistic PD have broadened since the creation of these scales; there has been a shift away 
from focusing only on grandiosity to include consideration of underlying narcissistic 
vulnerability (Manley, Roberts, Beattie, & Woodman, 2018).  Therefore, the Raskin and 
Novacek (1989) and Wink and Gough (1990) narcissism scales may not reflect current 
conceptualizations of narcissism despite their previously demonstrated reliability and validity.  




The introduction of the DSM-5 (American Psychiatric Association, 2013) and the 
previously discussed momentum toward classifying a dimensional model for PDs inspired a 
renewed attempt to develop PD scales for the MMPI-2.  Mulay et al. (2018) pooled the items 
from the scales described above to develop a set of PD Spectra scales for the MMPI-2 
(Hathaway, 1989) with consideration given to the DSM-5’s Sections II and III, ICD-10 (World 
Health Organization, 1993), and PDM-2 (Alliances of Psychoanalytic Organizations, 2017) 
models for PDs.  The authors’ aim was to create scales that could provide a bridge between the 
two models, or a “dimensionalized-categorical” model.3   
 Six individuals with expertise in PD assessment (five psychologists and one advanced 
doctoral student) rated each previously existing PD scale item on its direct content validity for 
the PD in question and its “performative validity” (i.e., whether an individual with the PD in 
question would be likely to endorse the item; Johnson, 2004).  They were instructed to consider 
the PD conceptualizations included in ICD-10, PDM-2, and Sections II and III of DSM-5.  Raters 
scored items on each of the 16 PDs under investigation (antisocial, avoidant, borderline, 
dependent, depressive, histrionic, narcissistic-depleted/vulnerable, narcissistic-grandiose, 
obsessive-compulsive, paranoid, passive-aggressive, sadistic, schizoid, schizotypal, self-
defeating, and somatizing) using the following metric: 0 = “not relevant,” 1 = “somewhat 
relevant,” 2 = “quite relevant,” and 3 = “highly relevant.”  Two-way, random, single-rater 
agreement intra-class correlation coefficients (ICC; Shrout & Fleiss, 1979) were then calculated 
for each PD scale, along with content validity ratios (CVR).  CVRs were computed via the 
following formula, wherein N represents the total number of experts and E is the number of 
experts who rated the item as essential (i.e., a score of 2-3; Lawshe, 1975; Lynn, 1986):  
                                                 





CVR = (E – N/2) / (N – 2) 
 Items with CVRs ≥ .67 were retained and overlapping items were retained only on the 
scale with the higher CVR.  All scales were required to have at least 10 items.4  Rater discussion 
of theoretical considerations informed retention of some items with modest CVRs (i.e., .33) and 
overlapping items with equivalent CVRs on multiple scales.  The result was 12 PD Spectra 
scales that demonstrated strong CVRs and non-overlapping items: antisocial, avoidant, 
borderline, dependent, depressive, histrionic, narcissistic grandiose, obsessive compulsive, 
paranoid, schizoid, schizotypal, and somatizing.   
 The 12 scales were then tested on a sample of clinical outpatients (N = 1,030).  
Cronbach’s alpha and corrected item-total correlations were examined for each scale and item.  
Items with item-total correlations below .20 were excluded, and revisions to the 12 scales were 
made based on the following item-based criteria: item-total correlation ≥ .20 and lack of a higher 
significant correlation (p < .01, 2-tailed) with a non-parent PD scale.  One hundred items 
demonstrated a higher correlation to another PD scale (versus the parent scale); two members of 
the research team used theory as a guide to determine whether the items should be moved to a 
new scale, retained on their parent scale, or removed from further analyses.5   
 The clinical sample was then split into two subsamples (a development sample [N = 614] 
and a replication sample [N = 416]) and the item-analytic procedure was repeated on the 
development sample.  After item deletions based on the aforementioned criteria, analyses were 
repeated a third time on the replication sample and scales were finalized.  See Appendix 1 for 
final scale items (although items have been altered in compliance with copyright laws).  
                                                 
4 After final analyses, the schizoid PD Spectra scale had 9 items, but demonstrated adequate psychometric 
properties to be retained.  See Mulay et al. (2018) for details. 
5 After agreement was reached on 90/100 items, a third member of the research team evaluated the remaining 10 




 Results of the MMPI-2 item analyses for the Mulay et al. (2018) PD Spectra scales 
revealed good psychometric properties, with scale-wise Cronbach’s alphas ranging from .56 to 
.94 and item-total correlations ranging from .29 to .50.  Additionally, the scales correlated in 
expected directions with MMPI-2 validity, clinical, and PSY-5 scales.  Added benefits of these 
newly developed PD Spectra scales over prior PD scales are the lack of item overlap between 
scales and the promotion of cross-model connection between categorical and dimensional 
conceptualizations of PDs.  However, the underlying factor structure of the PD Spectra Scales is 
so far unknown.  Examination of the factor structure of the PD Spectra scales is needed to 
provide further evidence of the psychometric properties of the scales and to test their clinical 
utility as measures of PD pathology.  The current studies aim to fill these gaps by performing 
exploratory and confirmatory factor analyses of the items corresponding to the PD Spectra scales 
and examining the criterion validity and clinical utility statistics of the factors emerging from 
these analyses.  Although the PD Spectra Scales are organized into specific PD categories, it was 
predicted that results of the factor analyses would reveal an underlying dimensional-hybrid 





CHAPTER THREE: STUDY 1 
 Study 1 consisted of exploratory analyses to determine the item-level factor structure of 
the Mulay et al. (2018) PD Spectra scales (hereafter referred to as the PD Spectra scales), in a 
first step toward ascertaining whether their underlying structure reflects a dimensional model of 
PDs.  Bifactor analysis was the analytic method chosen to answer this question, as it allowed PD 
scale items to load on a large general factor that encapsulated the variance shared across the item 
pool, with additional specific factors that captured unique domains of the items.   
 It was hypothesized that the factor structure of the scales would reveal a dimensional item 
configuration reflective of the DSM-5 AMPD.  Therefore, it was predicted that an exploratory 
bifactor model would fit the PD Spectra scales sample data well, with one general factor 
representing overall distress in the areas of interpersonal relationships and identity, to mirror 
Criterion A of the AMPD.  Other PD measurements developed based on the AMPD have 
supported a one-factor or bifactor structure reflective of a general distress factor (J. L. Anderson 
et al., 2013; Busch, Morey, & Hopwood, 2017; Hentschel & Livesley, 2013), and evidence exists 
that clinical severity is the most important indicator of personality pathology (Hopwood et al., 
2011). 
 In addition, it was hypothesized that five specific factors would emerge in the exploratory 
bifactor model, with each factor representing one of the five maladaptive personality trait 
subgroupings provided by Criterion B of the AMPD: negative affectivity, detachment, 
antagonism, disinhibition, and psychoticism.  This specific (or second-order) factor structure has 
been identified in similar studies of PD measurement development inspired by the AMPD (J. L. 
Anderson et al., 2013; Busch et al., 2017), and is conceptually linked to the Five-Factor Model of 




Chang, Bock, and Schilling (2000) resulted in a 10-factor solution with factors representing 
distrust, self-doubt, fitness, serenity, rebelliousness, instrumentality, irritability, artistry, 
sociability, and self-reliance.  These findings inspired a flexible and exploratory mindset in 
determining the specific factor structure of the PD Spectra scale item pool, although Leonelli et 




 Participants were 1,030 individuals presenting to a university-based psychological clinic 
for psychological evaluation and/or treatment.  The demographic makeup of participants was 
generally consistent with individuals presenting to a community-based clinic in the Southeastern 
United States.  Participants had the following demographic characteristics: 52.5% female (n = 
541), 47.5% male (n = 489); mean age of 31.63 years (SD = 11.63); mean years of education 
14.38 (SD = 2.57); 53.7% never married, 25.8% currently married.  Racial data was only 
available for 820 (79.6%) of the participants, but for those whose racial makeup was known, 
73.3% identified as Caucasian, 3.2% as African-American, 1.3% as East/South Asian or Pacific 
Islander, 1.2% as multiracial, 0.3% as Native American, and 0.3% selected “other race”.  Type of 
service sought was identified for 865 (84.0%) of participants.  Of those for whom service sought 
was known, 38.7% sought individual psychotherapy; 26.0% sought psychoeducational 
evaluation; 6.7% sought psychological evaluation; 4.6% sought couples, family, or group 
therapy; 4.0% sought court-ordered child custody evaluation; 1.1% sought social security or 
disability evaluation; and 1.0% each sought vocational rehabilitation evaluation, fitness for duty 





 Data were collected from a de-identified, archival sample of clinical patients who 
completed the MMPI-2 as part of clinic intake procedures between 2005 and 2015.  The clinic 
was a university psychological clinic associated with a clinical psychology doctoral program.  
Fees were determined on a sliding scale and the clinic primarily served individuals from the local 
community.  Referrals to the clinic were commonly received from local mental health 
practitioners, nearby universities, the court system, primary care offices, other community 
members, and nearby outpatient mental health centers and crisis care centers.  All participants 
signed a waiver before testing authorizing the use of their test results for research purposes.  
Participants completed the measures using pencil and paper and the MMPI-2 was scored using 
computer software. 
Measures 
 MMPI-2. The Minnesota Multiphasic Personality Inventory, Second Edition (MMPI-2; 
Butcher et al., 2001) is an oft-used, empirically developed measure of adult personality structure 
and clinical symptomology. The MMPI-2 is a self-report measure that consists of 567 true/false 
items composed at a 5th grade reading level.  Normative statistics were based on a nationally 
representative community sample of adult men and women between the ages of 18 and 80 (1,462 
females and 1,138 males; Butcher et al., 2001).  Validity of MMPI-2 scale norms has been 
established for adults over the age of 20 and across occupations and income levels (Weiner & 
Greene, 2008).  Test-retest correlations average .74 for the clinical scales and .85 for the content 
scales, meaning that an individual’s true scores fall within the standard error of measurement 
about two thirds of the time (Butcher et al., 2001).  For this study, MMPI-2 data were extracted 




met the following validity criteria: Cannot Say ≤ 30, VRIN ≤ 80T, F and FBS ≤ 110T, F(p) ≤ 
100T, L ≤ 80T, K ≤ 75T, and S ≤ 75T (Archer, Fontaine, & McCrae, 1998; Archer, Handel, & 
Couvadelli, 2004; Butcher et al., 2001; Rothke et al., 2000). 
 PD Spectra scales item pool. 220 items from the MMPI-2 constitute the PD Spectra 
scales item pool that was used in the present study.  Items were determined based on the results 
of a scale development study conducted by Mulay et al. (2018; see literature review for more 
information).   The PD Spectra are made up of the following scales (Cronbach’s alpha statistics 
are in parentheses following each scale, and represent the range of reliability observed for three 
samples in Mulay et al., 2018): antisocial (α = .77-.86), avoidant (α = .82-.88), borderline (α = 
.82-.90), dependent (α = .67-.84), depressive (α = .85-.94), histrionic (α = .74-.80), narcissistic 
grandiose (α = .67-.83), obsessive compulsive (α = .56-.75), paranoid (α = .76-.87), schizoid (α = 
.63-.80), schizotypal (α = .67-.87), and somatizing (α = .67-.85). 
 Demographics.  Participant demographics were collected both from the MMPI-2 
protocols (i.e., age, gender, date of intake, marital status) and patient paper files from clinic 
archives (i.e., race and purpose of assessment).  Trained undergraduate research assistants 
extracted data from paper files and entered the information into a digital database for analysis. 
Data Analytic Plan 
 To address the aim of Study 1, items corresponding to the 12 PD Spectra scales were 
subjected to exploratory factor and bifactor analyses (EFA and EBFA).  Although higher-order 
modeling is often used in the examination of psychological phenomena, bifactor models have 
been shown to best fit data for multidimensional measures such as the WAIS-III (Brunner, Nagy, 
& Wilhelm, 2012), WISC-V (Dombrowski, Canivez, Watkins, & Beaujean, 2015), Outcome 




Scale (OAS; Reise, Moore, & Haviland, 2010), HEXACO Personality Inventory (Anglim et al., 
2017), and the 50-item International Personality Inventory Pool (IPIP; Biderman, Nguyen, 
Cunningham, & Ghorbani, 2011).  Once the underlying factor structure of the PD Spectra Scales 
was determined through EFA, bifactor modeling provided a method for further examining the 
Scales that is congruent with the conceptualization of PD dimensionality described above.   
 Bifactor modeling allows for latent variables of interest and group factors to compete to 
explain item variance and avoids placing factors “higher” or “lower” than one another as in 
higher-order modeling.  Specifically, in a bifactor model each item loads onto a general factor, 
which represents individual differences in the target variable of most interest (e.g., interpersonal 
dysfunction and identity disturbance).  The specific or nuisance factors represent common 
factors that explain additional item variance that is not accounted for by the general factor (e.g., 
PD trait groupings).  Thus, bifactor modeling aligns with the conceptual model for the AMPD, as 
the general dysfunction criterion (Criterion A) is conceptualized as separate from the specific 
trait factors (Criterion B), yet Criterion A is the most descriptive of overall PD pathology.  See 
Figure 1 for sample figural representations of a correlated factors model and a bifactor model. 
 First, the underlying factor structure of the PD Spectra Scales item pool was determined 
using exploratory factor analysis (EFA).  In the context of an initial EFA, possible factor 
constellations that fell outside of the hypothesized five-factor model were examined.  Empirical 
factor extraction criteria (Gorsuch, 1983) and factor interpretability and compliance with simple 
structure (Thurstone, 1931) informed factor extraction.  Specifically, eigenvalues > 1 (Kaiser, 
1960) and the scree test (Cattell, 1966) were examined to identify the appropriate range of 
factors to further explore in modeling the data.  As recommended by Muthén (personal 




item pool, an EFA was first run with unweighted least squares multivariate (ULSMV) estimation 
on all 220 items to estimate an initial factor structure.  Items were retained if they loaded ≥ .40 
on any one factor and < .30 on any other factor (McDonald, 1999).  If items loaded < .40 on any 
one factor or if item cross-loadings onto more than one factor exceeded .30, the items were 
removed and the EFA repeated.  Once the item pool was reduced such that all items met these 
initial criteria, EFA was run with weighted least squares multivariate (WLSMV) estimation.  
WLSMV is recommended for modeling categorical data due to its robustness and because it does 
not assume normality of variable distribution, which is particularly important in applied research 
(Brown, 2014).  Missing data were handled using pairwise deletion, as this is the only option for 
WLSMV estimation of dichotomous variables.   
 Factor interpretability, factor correlations, and model fit indices informed the choice of a 
final EFA model.  Specifically, model fit was determined through the use of three goodness-of-
fit indices: Comparative Fit Index (CFI), root mean square error of approximation (RMSEA), 
and standardized root mean square residuals (SRMR). As recommended by Marsh, Hau, and 
Wen (2004), the criteria to establish acceptable model fit were: CFI ≥ 0.90, RMSEA < 0.08, and 
SRMR < 0.08.  Of note, AIC and BIC model fit statistics were not considered because they are 
not available for WLSMV estimation.   
 Next, EBFA was run on the resulting item pool with factors rotated using the bifactor 
target rotation, or bi-geomin, method (Reise, Moore, & Maydeu-Olivares, 2011).  Scree plot and 
factor interpretability informed the range of factor solutions explored in this stage of analysis.  
The final EBFA factor structure was determined based on factor interpretability, proportion of 




SRMR).  See below for background information on exploratory bifactor parameter estimation 
methods and justification of the use of the bifactor target rotation method.  
 There are two common approaches to parameter estimation in exploratory bifactor 
modeling: the Schmid-Leiman orthogonalization (SL; Schmid & Leiman, 1957) and the bifactor 
target rotation method (Reise et al., 2011).  The SL is a re-parameterization of higher-order 
modeling that reveals how the measured variables are related to the second-order factor and 
versions of the first-order factors that have been residualized (Dombrowski et al., 2015).  
Problematically, the SL overestimates general factor loadings and underestimates specific factor 
loadings in the presence of non-zero cross-loadings (Reise, 2012).  In addition, the SL method 
introduces an issue of proportionality constraints, wherein it is assumed that the ratio of the 
general to specific factor loadings are equivalent for all items (Yung, Thissen, & McLeod, 1999).  
Proportionality is highly unlikely in population data and, therefore, assuming proportionality 
greatly limits understanding of the true relationships between general and specific factors.   
 Alternatively, the bifactor target rotation method requires a priori specification of a 
factor pattern matrix, including specified and unspecified elements (Reise, 2012).  The factor 
pattern matrix is constructed based on theory or preliminary data analyses.  This method has 
created models that (1) correctly estimated solutions even when items cross-loaded onto multiple 
group factors and (2) matched well with true population parameters (Reise et al., 2011).  The 
bifactor target rotation method was chosen for use in this study due to the likelihood the specific 
factors would be correlated.  Therefore, PD Spectra scale items were likely to cross-load onto 
multiple factors, making application of the Schmid-Leiman orthogonalization to bifactor 




 All EBFA was conducted using weighted least squares multivariate (WLSMV) 
estimation.  This method is appropriate to use when factor determinants are dichotomous 
(Muthén & Muthén, 2017).  All EFA and EBFA were conducted using Mplus version 8.1 
(Muthén & Muthén, 2017).  Mplus EBFA procedures account for dichotomous items, so 
polychoric matrix computation was not necessary in these analyses.  Additionally, all exploratory 
analyses were run with oblique group factors to allow for correlation amongst factors.6  
Results 
Exploratory Factor Analysis 
 Table 1 displays frequencies for all PD Spectra Scale items (all tables and figures are 
located in Appendix 2).  Across 220 variables, the average proportion of missing data was 0.2% 
(range: 0-2.6%).  EFA was run with ULSMV estimation on all 220 items to determine initial 
factor structure. Figure 2 displays a scree plot of an initial exploratory bifactor analysis, and 
Table 2 presents the corresponding eigenvalues.  The scree plot showed a dominant first factor, 
and eigenvalues were greater than 1.00 for 60 factors (44.04-1.02).  The ratio of the first to 
second factor eigenvalue was 44.04 to 17.40, indicating a common variance underlying the 
homogeneity and internal consistency across the 220 items.  Slight bends in the scree plot 
emerged at 3, 6, and 10 factors.  Reasoning about the potential interpretability of the number of 
factors led to final examination of 1-15 factor models.  Interpretability analysis of the specific 
factor structures that emerged led to further examination of 5-13 factors (i.e., factor structures for 
1-4 and 14-15 factors included factors that encompassed multiple concepts or were otherwise not 
                                                 
6 Oblique factor rotation was chosen because the belief that personality factors (e.g., FFM, Big Five) are 
uncorrelated has been called into question by findings of moderate intercorrelations amongst specific personality 
factors, which have arguably been missed in studies that tested orthogonal models (Digman, 1997; Musek, 2007).  
For instance, meta-analysis conducted by Van der Linden et al. (2010) obtained a mean absolute correlation of .23 




interpretable based on item content).  For factor models with 5-13 factors, items were retained if 
they loaded ≥ .40 on any 1 factor and < .30 on any other factor for any model.  Sixty-five of the 
original 220 items did not meet these criteria (i.e., displayed significant cross-loading or poor 
loading on a single factor in all models) and were deleted. 
 EFA was then run with WLSMV estimation on 155 items for 5-13 factors.  Model fit was 
good for all models (e.g., CFI ≥ 0.90, RMSEA < 0.08, and SRMR < 0.08), but interpretability 
favored a model with 5 or 6 factors.  Specifically, models with more than 6 factors included 
factors wherein no items loaded ≥ .40 on the factor and/or factors were not interpretable based on 
item content.  Nine rounds of item deletion were conducted using the same item deletion criteria 
until a final factor model could be fit to the data.  Items had to load poorly on all factor structures 
still under consideration in order to be deleted at each round.  Following the final round of item 
deletion, a 6-factor EFA model comprised of 53 items offered the cleanest solution.  Model fit 
was good for the final 6-factor solution (χ² = 1825.11 (1122), RMSEA = .03, CFI = .96, SRMR = 
.05).  
 The first factor was defined by somatization items (e.g., “frequent stomach aches,” 
“tenderness atop head”), suggesting a clear dimension of somatization in the personality 
measurement of the overall scale.  The second factor loaded onto antisocial and paranoid PD 
Spectra Scale items, and included one obsessive-compulsive PD item (“[I am] just as good as 
experts”).  Thus, this factor was determined to measure a personality domain of antagonistic 
suspiciousness, rather than reflecting a particular PD.  Factor 3 included histrionic PD scale 
items (e.g., “worries melt in a lively crowd”) and revealed negative loadings for one avoidant 
(“more likely to be a wallflower at a party”) and two schizoid (“happiest alone” and “avoids 




extraversion.  The fourth factor loaded onto depressive PD items (e.g., “empty/meaningless 
life”), as well as one borderline item (“frequent suicidal thoughts”) and a negatively loading 
narcissistic item (“feel important”).  Given the item content, this factor seemed to best reflect 
depression symptomology.  Factor 5 included dependent PD items (e.g., “easily defeated in 
arguments”), one borderline item (“it is easy to make me cry”) and one avoidant item (“easily 
embarrassed”).  Given the emphasis on bowing to others and the absence of eliciting caretaking 
by others, this factor was thought to reflect the personality domain of passivity, rather than 
dependent PD.  Finally, factor 6 was made up of borderline PD items centering on angry affect 
(e.g., “hotheaded”).  Therefore, this factor represented tendency toward anger rather than 
borderline PD.  The following factor names were assigned to the final 6-factor model: 
somatizing (factor 1, 10 items), antagonistic suspiciousness (factor 2, 10 items), extraversion 
(factor 3, 10 items), depression (factor 4, 9 items), passivity (factor 5, 8 items), and anger (factor 
6, 7 items).  See Table 3 for factor loadings and item content.   
 Table 4 includes factor correlations for the EFA model.  All factors exhibited significant 
(p < .05) correlations with at least one other factor. Somatizing (F1) correlated positively with 
antagonistic suspiciousness (F2; r = .21), depression (F4; r = .29), passivity (F5; r = .12), and 
anger (F6; r = .27).  In other words, individuals who endorsed somatizing were more likely to 
also endorse antagonistic suspiciousness, depression, passivity, and anger.  Somatizing (F1) 
correlated negatively with extraversion (F3; r = -.14), indicating individuals who endorsed 
somatizing were less likely to also endorse extraversion.  Antagonistic suspiciousness (F2) was 
positively correlated with depression (F4; r = .21), passivity (F5; r = .19), and anger (F6; r = 
.32). Thus, those who endorsed antagonistic suspiciousness were more likely to also endorse 




(F4; r = -.34) and passivity (F5; r = -.23), meaning individuals who reported extraversion were 
less likely to report depression and passivity.  Depression (F4) correlated positively with 
passivity (F5; r = .32) and anger (F6; r = .22), suggesting those who self-reported depressive 
symptoms were more likely to also endorse passivity and angry affect.  Finally, passivity (F5) 
correlated positively with anger (F6; r = .20), meaning those who endorsed passivity were more 
likely to endorse anger.  Correlations between antagonistic suspiciousness (F2) and extraversion 
(F3), and extraversion (F3) and anger (F6) were not significant.   
Exploratory Bifactor Analysis 
 Next, EBFA with WLSMV estimation, oblique bi-geomin rotation, and theta 
parameterization was run on the 53 items from the final EFA model.  Figure 3 displays a scree 
plot for the 53-item pool, and Table 5 presents the corresponding eigenvalues.  The scree plot 
shows a dominant first factor, and eigenvalues were greater than 1.00 for 13 factors (11.27-1.00).  
The ratio of the first to second factor eigenvalue was 11.27 to 5.69, indicating a common 
variance underlying the homogeneity and internal consistency across the remaining 53 items.  
Slight bends in the scree plot emerged at 3 and 8 factors.  Models with 3 and 4 factors exhibited 
mediocre to poor model fit (χ² = 4050.75 (1272), RMSEA = .05, CFI = .83, SRMR = .09 and χ² = 
3125.62 (1221), RMSEA = .04, CFI = .89, SRMR = .08, respectively), and therefore were 
discarded. The EBFA models with 8-13 factors were discarded due to lack of interpretability of 
the factors.  Models with 5 and 7 factors exhibited significant cross-loadings of items on multiple 
specific factors.  Therefore, the 6-factor EBFA model provided the cleanest solution and 
indicated the fewest number of item cross-loadings.  The 6-factor EBFA model fit was good (χ² 
= 1825.11 (1122), RMSEA = .03, CFI = .96, SRMR = .05).  It was not possible to compare EFA 




the models are compared qualitatively in the discussion section.  See Table 6 for model fit 
indices for EFA and EBFA analyses.  
 All but three items from the 53-item pool demonstrated statistically significant loadings 
onto the general factor.  Items that did not load significantly on the general factor were: “like 
loud, fun parties” (item 86), “enjoy flirting” (item 189), and “like being friends with pranksters” 
(item 231).  The 48 items that demonstrated moderate to high loadings (i.e., ≥ .30) onto the 
general factor included items from the somatizing (9 items), depressive (7 items), borderline (7 
items), paranoid (6 items), dependent (6 items), histrionic (5 items), antisocial (3 items), avoidant 
(2 items), schizoid (2 items), and narcissistic (1 item) PD Spectra Scales.  Due to the 
expansiveness of the item content included in the general factor, the factor was thought to reflect 
overall psychological distress/psychopathology.  The five specific factors matched with 
somatizing (F1), extraversion (F3), depression (F4), passivity (F5), and anger (F6) from the EFA, 
with identical item content.  Only antagonistic suspiciousness (F2) was missing in the EBFA 
model, as the variance for those items was accounted for by the general factor.  Therefore, the 
following EBFA model specific factor names were assigned: somatizing (specific factor 1, 10 
items), extraversion (specific factor 2, 10 items), depression (specific factor 3, 9 items), passivity 
(specific factor 4, 8 items), and anger (specific factor 5, 7 items).  See Table 7 for factor loadings 
and item content.   
 Table 8 includes EBFA factor correlations.  As expected, extraction of a general factor in 
the bifactor analysis resulted in fewer significant (p < .05) correlations amongst the specific 
factors, and weaker correlations for those that were significant.  Somatizing (S1) was positively 
correlated with depression (S3; r = .18) and anger (S5; r = .14), indicating participants who 




was negatively correlated with extraversion (S2; r = -.09), meaning individuals who reported 
somatizing were less likely to endorse extraversion.  Extraversion (S2) negatively correlated with 
depression (S3; r = -.31) and passivity (S4; r = -.19), meaning individuals who endorsed 
extraversion were less likely to endorse depression and passivity.  Finally, depression (S3) was 
correlated with passivity (S4; r = .23).  In other words, those who self-reported depression 
symptoms were more likely to also endorse passivity.  Correlations between somatizing (S1) and 
passivity (S4), extraversion (S2) and anger (S5), depression (S3) and anger (S5), and passivity 





CHAPTER FOUR: STUDY 2 
Study 2 sought to confirm the exploratory bifactor model using a second clinical sample 
provided by Jones (2005; Aim 1) and utilized data from the Millon Clinical Multiaxial Inventory, 
second edition (MCMI-II; Millon et al., 1987) to establish criterion-related validity (Aim 2).  It 
was hypothesized that Aim 1 confirmatory bifactor analysis performed on the Study 2 sample 
would support the factor structure identified in the exploratory analyses described in Study 1 and 
demonstrate superior model fit to a correlated factors model.  To address Aim 2, correlational 
and regression analyses were performed to examine associations between the PD Spectra item 
pool general and specific factors and the MCMI-II personality scale scores (schizoid, avoidant, 
dependent, histrionic, narcissistic, antisocial, aggressive-sadistic, compulsive, passive-
aggressive, self-defeating, schizotypal, borderline, and paranoid).  Results of the criterion 
validity analyses served as benchmarks for interpreting the confirmatory analysis results.    
 Third, model-based internal consistency reliability statistics were examined for the 
confirmatory bifactor model (Aim 3).  Attention to these often unreported statistics provided 
additional information on the psychometric properties of the general and specific factors 
confirmed in Aim 1.  Reliability statistics also shed light on the potential clinical utility of the 
underlying factor structure of the PD Spectra Scale items.  Finally, these analyses revealed 
whether the factor structure could be used to develop a clinically useful alternative scoring 
scheme for the PD Spectra Scales item pool. 
Methods 
Participants 
 Study participants were 539 individuals presenting to military services branches of an 




Participants included retired and active duty military service members and their family members.  
The sample included 373 inpatient and 135 outpatient individuals.  Participants had the following 
demographic characteristics: 29.9% female (n = 161), 70.1% male (n = 378); mean age of 29.57 
years (SD = 9.71); mean years of education 13.45 (SD = 2.33); 65.5% White, 23.4% African 
American, 4.8% Hispanic, 2.6% Asian American, 0.6% American Indian, and 2.2% indicated 
another race.  
Procedure 
 Inpatient participants were administered the MMPI-2 and MCMI-II as part of a 
diagnostic evaluation that occurred during their hospitalization.  Most of the outpatient 
participants completed the measures as part of evaluations intended to answer diagnostic 
questions posed by other professionals (e.g., psychiatry, neurology) or guide treatment planning.  
Some outpatients may have competed the measures as part of fitness for duty, security clearance, 
or special duties selection evaluations.  All participants signed a waiver before testing 
authorizing that their test results could be used for research purposes.  Participants completed the 
measures using pencil and paper and measures were scored using computer software. 
Measures 
 MMPI-2.  See the Study 1 Methods section for a description of the MMPI-2 and record 
inclusion criteria.   
 PD Spectra scales item pool. See the Study 1 Methods section for a description of the 
MMPI-2 item pool used for this study.  
 MCMI-II.  The Millon Clinical Multiaxial Inventory, second edition (MCMI-II; Millon 
et al., 1987) is a 175-item, true/false, self-report questionnaire that measures clinical symptoms 




test in clinical practice (Piotrowski & Zalewski, 1993) that utilizes base rate scores rather than T 
scores.  The optimal base rate scale scores were determined using a sample of 1,292 clinical 
patients with a variety of presenting problems (Groth-Marnat, 2009).  Factor analyses of the 
scales have generally supported their organization, and reliability and validity have been well 
established (Groth-Marnat, 2009).  Finally, study of the comparative validity of MMPI-2 and 
MCMI-II scales found acceptable convergent and discriminant validity between the scales of the 
two measures (Wise, 1996).  MCMI-II records were included in this study only if participants 
omitted ten or fewer items and did not endorse any of the invalidity items.   
Data Analytic Plan 
Aim 1 
 As Study 1 resulted in well-fitting EFA and EBFA models, confirmatory factor (CFA) 
and confirmatory bifactor analyses (CBFA) were performed on the Study 2 sample based on the 
models identified in Study 1.  CBFA allows each item to load onto a general factor and only one 
specific factor.  The fixed factor identification method was used, which sets the scale of each 
latent variance to 1.0 to obtain standardized estimates (Little, Slegers, & Card, 2006).  All 
specific factors were specified as orthogonal, meaning all other specific factor cross-loadings 
were restrained to zero.  As Reise (2012) has recommended, CBFA was performed only after a 
careful EBFA to prevent inattention to the potentially distorting effects of restraining small 
cross-loadings to zero.   
 The criteria to establish acceptable model fit were: CFI ≥ 0.90 and RMSEA < 0.08. 
SRMR values are not available for confirmatory factor analyses in Mplus version 8.1, so they 
were not used to establish model fit.  Modification indices informed changes to the CFA and 




the DIFFTEST function was used to determine if adding an additional parameter (e.g., cross 
loading, correlated residual) resulted in a significant drop in chi-square.  All CFA and CBFA 
analyses were conducted using Mplus version 8.1 (Muthén & Muthén, 2017) using weighted 
least squares multivariate (WLSMV) estimation.  To account for the fact that all MMPI-2 items 
are dichotomous, CBFA models were estimated using theta parameterization, and Mplus 
automatically estimated probit regressions for the factor indicators regressed on the factors 
(Muthén & Muthén, 2017).  As in Study 1, missing data was handled using the pairwise deletion 
procedure. 
Aim 2 
 Next, criterion validity was examined by estimating correlations between the MCMI-II 
Clinical Scales and each CFA and CBFA factor.  Second, to further parse the criterion validity of 
the factors, the MCMI-II Clinical Scales were regressed onto the factors identified in the CFA 
and CBFA.  All of these analyses were incorporated into the confirmatory factor models, in order 
to increase power and decrease parameter estimation bias.  Correlation and regression results 
were interpreted in the context of personality disorder theory and existing categorical and 
dimensional conceptualizations of PD (i.e., DSM-5’s Sections II and III models).  Results 
reported on criterion-based validity information about the factors gleaned through these analyses. 
Aim 3 
 Lastly, additional psychometrics of the final CBFA model were examined by observing 
the omega total (ω) and omega hierarchical (ωh) model-based reliability indices (Canivez, 
2016). These statistics can only be computed for bifactor models.  The omega total coefficient is 
the latent variable proxy to coefficient alpha, as it communicates the proportion of variance in 




& Haviland, 2016).  The omega hierarchical coefficient measures the variance attributable to 
one latent variable at a time.  The omega hierarchical coefficient, therefore, reveals the 
percentage of systematic variance in unit-weighted total scores attributable to individual 
differences on the general factor.  Therefore, observation of the omega total and omega 
hierarchical coefficients enabled understanding of the multidimensionality of the PD Spectra 
Scale item pool.  Overall, these analyses shed light on the potential clinical utility of establishing 
an alternative scoring method for the PD Spectra scales item pool that reflects a dimensional-
hybrid model.  Omega statistics were computed using the Omega program for Mac OS (Watkins, 
2013). 
Results 
Aim 1   
 Confirmatory Factor Analysis.  Table 9 displays frequencies for the 53 MMPI-2 items 
in the final item pool.  Across 53 variables, the average proportion of missing data was 0.2% 
(range: 0-1.1%).  CFA with WLSMV estimation was run on the 6-factor model identified in the 
Study 1 EFA analysis.  Model fit was good (χ² = 2402.60 (1362), RMSEA = .04, CFI = .937).  
However, modification indices showed a 100.35 improvement in chi-square was possible if item 
86 (“like loud, fun parties”) from the extraversion factor (F3) was allowed to cross-load on 
antagonistic suspiciousness (F2).  This change also made theoretical sense based on the 
preponderance of antisocial PD items included in the factor, as sensation-seeking behavior 
commonly coincides with antisocial presentations (Mann et al., 2017).  As such, item 86 was 
allowed to cross-load on antagonistic suspiciousness (F2), and the resulting CFA model fit 
statistics showed statistically significant (p < .01) improvement over the first model (χ² = 
                                                 




2308.19 (1361), RMSEA = .04, CFI = .94; Δχ² = 52.50, Δdf = 1).  Modification indices for the 
revised CFA model did not suggest additional alterations that would result in a significant 
change in chi-square.  Thus, a model with a single cross-loaded item was deemed the final CFA 
model (see Table 10 for factor loadings).  
 Table 11 includes factor correlations for the final CFA model.  Correlations between 
factors were substantially higher in the CFA model compared to the EFA model.  All factors 
were significantly correlated with one another.  Somatizing (F1) correlated positively with 
antagonistic suspiciousness (F2; r = .61), depression (F4; r = .59), passivity (F5; r = .63), and 
anger (F6; r = .58).  In other words, individuals who endorsed somatizing were more likely to 
endorse antagonistic suspiciousness, depression, passivity, and anger.  Somatizing (F1) was 
negatively correlated with extraversion (F3; r = -.41), meaning those who reported somatizing 
were less likely to endorse extraversion.  Antagonistic suspiciousness (F2) was positively 
correlated with depression (F4; r = .61), passivity (F5; r = .61), and anger (F6; r = .62).  
Therefore, participants who self-reported antagonistic suspiciousness were more likely to self-
report depression, passivity, and anger.  Antagonistic suspiciousness (F2) correlated negatively 
with extraversion (F3; r = -.45), indicating individuals who endorsed antagonistic suspiciousness 
were less likely to endorse extraversion.  Extraversion (F3) correlated negatively with depression 
(F4; r = -.56), passivity (F5; r = -.58), and anger (F6; r = -.26).  In other words, individuals who 
reported extraversion were less likely to report depression, passivity, and anger.  Depression (F4) 
was positively associated with passivity (F5; r = .64) and anger (F6; r = .55), meaning those who 
endorsed depression were more likely to also endorse passivity and anger.  Passivity (F5) 
correlated positively with anger (F6; r = .47), indicating those who reported passivity were more 




that the factors measured aspects of personality/affective experience (e.g., antagonistic 
suspiciousness, extraversion, passivity, and anger) and internalizing psychopathology (e.g., 
somatizing and depression), and these concepts tend to be interrelated.  Additionally, the ability 
to fit a bifactor model to the data was indicative of high correlations between factors (i.e., 
common variance among items is pulled up into the general factor), and correlations among 
factors are often stronger in CFA because latent constructs are free of measurement error.  It is 
possible as well that strong correlations between factors were influenced by characteristics of the 
Study 2 sample, particularly given that the sample included military inpatients.  These 
individuals may have reported greater severity of symptoms overall, along with higher 
comorbidity that could account for factor inter-correlations. 
 Confirmatory Bifactor Analysis.  Next, CBFA with WLSMV estimation and theta 
parameterization was run on the model that resulted from the Study 1 EBFA analysis.  Model fit 
was good (χ² = 2343.43 (1333), RMSEA = .04, CFI = .93).  Modification indices showed that 
correlating the residual for item 110 (“Most people will act unfairly to get ahead”) with that of 
81 (“Most people would lie to do better than others”) and the residual for 138 (“People are 
plotting against me”) with that of 99 (“Someone is out to get me”) would decrease chi-square by 
116.41 and 120.58 points, respectively.  However, reasoning based on the true item content (as 
content has been altered in this manuscript in accordance with copyright laws) did not support 
making these changes.  Modification indices did not suggest any other alterations to the model 
that would result in a significant change in chi-square.  Thus, the original CBFA model was 
accepted as the final CBFA model (see Table 12 for factor loadings).  Unfortunately, it was not 
possible to quantitatively compare CFA and CBFA model fit statistics because the models 




and therefore were not nested within one another.  All CFA and CBFA model fit statistics 
(including those of the Aim 2 models, described below) are included in Table 13. 
Aim 2 
 Confirmatory Factor Analysis correlational analyses.  Correlations between the 6 
latent factors and the MCMI-II Clinical Scales (schizoid, avoidant, dependent, narcissistic, 
antisocial, histrionic, aggressive, compulsive, passive-aggressive, self-defeating, schizotypal, 
borderline, and paranoid) were added to the CFA model.  See Table 14 for MCMI-II Clinical 
Scale score descriptives and Table 15 for scale correlations.  The MCMI-II Clinical Scale scores 
were z-transformed prior to being added to the CFA model, due to a convergence issue related to 
large numerical values associated with scale variances (the same was true for the CBFA criterion 
validity analyses, described below).  The resulting model fit for the CFA model was good (χ² = 
3493.90 (1985), RMSEA = .04, CFI = .91).   
 Table 16 includes CFA correlation statistics.  A significant, positive association was 
observed between self-reported somatizing and MCMI-II passive-aggressive (r = .41), avoidant 
(r = .40), schizotypal (r = .38), self-defeating (r = .37), borderline (r = .35), schizoid, (r = .29), 
paranoid (r = .22), antisocial (r = .17), and aggressive/sadistic (r = .12) PD scale scores.  In other 
words, individuals who endorsed somatizing scored higher on the avoidant, schizoid, passive-
aggressive, self-defeating, schizotypal, aggressive/sadistic, borderline, antisocial, and paranoid 
PD scales.  Somatizing was negatively associated with compulsive (r = -.18) and histrionic (r = -
.17) PD scale scores, such that individuals who endorsed somatizing scored lower on the 
histrionic and compulsive scales. 
 Antagonistic suspiciousness (F2) was positively associated with passive-aggressive (r = 




antisocial (r = .34), and paranoid (r = .34) PD scale scores.  In other words, those who self-
reported antagonistic suspiciousness self-reported higher passive-aggressive, avoidant, self-
defeating, schizotypal, antisocial, paranoid, and borderline PD scale scores.  Antagonistic 
suspiciousness was not negatively associated with any of the MCMI-II Clinical Scales. 
 Extraversion (F3) was negatively correlated with schizoid (r = -.65), avoidant (r = -.59), 
schizotypal (r = -.53), self-defeating (r = -.36), passive-aggressive (r = -.29), borderline (r = -
.22), and paranoid (r = -.10) PD scale scores, such that individuals who endorsed extraversion 
scored lower on the schizoid, avoidant, self-defeating, passive-aggressive, borderline, paranoid, 
and schizotypal scales.  Extraversion was positively correlated with histrionic (r = .58) and 
narcissistic (r = .29) PD scale scores, meaning those who reported extraversion scored higher on 
the histrionic and narcissistic scales.  
 Depression (F4) was positively association with avoidant (r = .53), self-defeating (r = 
.49), schizotypal (r = .46), borderline (r = .45), passive-aggressive (r = .45), and schizoid (r = 
.44) PD scale score.  In other words, participants who endorsed depression scored higher on the 
schizoid, avoidant, passive-aggressive, self-defeating, schizotypal, and borderlines scales.  In 
addition, depression was negatively associated with compulsive (r = -.33), histrionic (r = -.33), 
and narcissistic (r = -.19) PD scale scores, such that those who reported depression scored lower 
on the histrionic, narcissistic, and compulsive scales.  
 Passivity (F5) was positively correlated with avoidant (r = .62), self-defeating (r = .61), 
schizotypal (r = .55), schizoid (r = .44), passive-aggressive (r = .43), dependent (r = .41), and 
borderline (r = .41) MCMI-II scale scores.  Therefore, individuals who reported passivity scored 
higher on the schizoid, avoidant, dependent, passive-aggressive, self-defeating, schizotypal, and 




.28), compulsive (r = -.20), and aggressive/sadistic (r = -.11) scales, such that those who 
endorsed passivity scored lower on the narcissistic, aggressive/sadistic, and compulsive scales. 
 Finally, anger (F6) was positively correlated with passive-aggressive (r = .71), borderline 
(r = .61), antisocial (r = .56), aggressive/sadistic (r = .52), self-defeating (r = .44), paranoid (r = 
.42), avoidant (r = .39), schizotypal (r = .38), narcissistic (r = .31), and schizoid (r = .12) PD 
scale scores.  In other words, participants who endorsed anger scored higher on the schizoid, 
avoidant, narcissistic, antisocial, aggressive/sadistic, passive-aggressive, self-defeating, 
schizotypal, borderline, and paranoid scales.  In addition, anger was negatively associated with 
compulsive (r = -.37), dependent (r = -.26), and histrionic (r = -.12) PD scale score, such that 
those who endorsed anger scored lower on the dependent, histrionic, and compulsive scales.  
 Confirmatory Factor Analysis regression analyses.  Next, regression analysis was used 
to examine whether the 6 latent CFA factors were uniquely associated with MCMI-II Clinical 
Scales.  Overall model fit was good (χ² = 3493.90 (1985), RMSEA = .04, CFI = .91).  See Table 
17 for CFA model results.  The 6 CFA factors explained 44.9% of the overall variance in the 
MCMI-II schizoid scale (R2 = .45, F(6,539) = 72.25, p < .01).  The schizoid scale was positively 
associated with depression (F4; β = .146, p < .05), such that individuals who scored higher on the 
schizoid scale also scored higher on depression.  Schizoid scale score was negatively associated 
with extraversion (F3; β = -.55, p < .05) and anger (F6; β = -.17, p < .05).  In other words, 
individuals who scored higher on the schizoid scale endorsed less extraversion and anger. 
 The 6 CFA factors explained 48.4% of the overall variance in the avoidant scale (R2 = 
.48, F(6,539) = 83.17, p < .01).  The avoidant scale was positively associated with depression 
(F4; β = .11, p < .05), passivity (F5; β = .35, p < .05) and anger (F6; β = .12, p < .05), meaning 




anger. Additionally, avoidant scale score was negatively associated with extraversion (F3; β = -
.33, p < .05), such that individuals who endorsed higher levels of avoidant pathology endorsed 
lower levels of extraversion.  
 The 6 CFA factors explained 51.4% of the overall variance in the dependent scale (R2 = 
.51, F(6,539) = 93.78, p < .01).  Dependent scale score was positively associated with 
extraversion (F3; β = .28, p < .05) and passivity (F5; β = .94, p < .05), such that participants who 
scored higher on the dependent scale endorsed more extraversion and passivity.  The dependent 
scale was negatively associated with depression (F4; β = -.16, p < .05) and anger (F6; β = -.52, p 
< .05), meaning individuals with higher dependent scale scores scored lower on depression and 
anger. 
 The 6 CFA factors explained 44.2% of the overall variance in the histrionic scale (R2 = 
.44, F(6,539) = 70.23, p < .01).  The histrionic scale was positively associated with extraversion 
(F3; β = .56, p < .05) and anger (F6; β = .40, p < .05), such that individuals who scored higher on 
the histrionic scale endorsed higher levels of extraversion and anger.  Additionally, histrionic 
scale score was negatively associated with depression (F4; β = -.22, p < .05).  In other words, 
those who scored higher on the histrionic scale scored lower on depression. 
 The 6 CFA factors explained 41.9% of the overall variance in the narcissistic scale (R2 = 
.42, F(6,539) = 63.94, p < .01).  The narcissistic scale was positively associated with antagonistic 
suspiciousness (F2; β = .28, p < .05), extraversion (F3; β = .14, p < .05), and anger (F6; β = .55, 
p < .05), meaning participants who scored highly on the narcissistic scale also scored highly on 
antagonistic suspiciousness, extraversion, and anger.  Narcissistic scale score was negatively 
associated with depression (F4; β = -.28, p < .05) and passivity (F5; β = -.44, p < .05), such that 




 The 6 CFA factors explained 38.8% of the overall variance in the antisocial scale (R2 = 
.39, F(6,539) = 56.21, p < .01).  Antisocial scale score was positively associated with 
antagonistic suspiciousness (F2; β = .20, p < .05) and anger (F6; β = .65, p < .05), indicating 
participants who scored higher on the antisocial scale also scored highly on antagonistic 
suspiciousness and anger.  The antisocial scale was negatively associated with passivity (F5; β = 
-.25, p < .05), such that those who scored highly on the antisocial scale endorsed less passivity. 
 The 6 CFA factors explained 44.1% of the overall variance in the aggressive/sadistic 
scale (R2 = .44, F(6,539) = 69.95, p < .01).  Aggressive/sadistic scale score was positively 
associated with anger (F6; β = .73, p < .05), such that participants who scored higher on the 
aggressive/sadistic scale also scored higher on anger.  The aggressive/sadistic scale was 
negatively associated with passivity (F5; β = -.49, p < .05), meaning individuals who scored 
higher on the aggressive/sadistic scale scored lower on passivity. 
 The CFA factors explained 20.2% of the overall variance in the compulsive scale (R2 = 
.20, F(6,539) = 22.44, p < .01).  Compulsive scale score was positively associated with 
somatizing (F1; β = .14, p < .05), such that individuals who scored highly on the compulsive 
scale also endorsed high levels of somatizing.  The compulsive scale was negatively associated 
with extraversion (F3; β = -.23, p < .05), depression (F4; β = -.32, p < .05), and anger (F6; β = -
.28, p < .05), meaning those who scored highly on the compulsive scale endorsed less 
extraversion, depression, and anger. 
 The 6 CFA factors explained 53.0% of the overall variance in the passive-aggressive 
scale (R2 = .53, F(6,539) = 99.99, p < .01).  Passive-aggressive scale score was positively 
associated with anger (F6; β = .65, p < .05).  In other words, participants who scored higher on 




 The 6 CFA factors explained 42.1% of the overall variance in the self-defeating scale (R2 
= .42, F(6,539) = 64.47, p < .01).  The self-defeating scale was positively associated with 
depression (F4; β = .13, p < .05), passivity (F5; β = .53, p < .05), and anger (F6; β = .22, p < .05), 
meaning individuals who scored higher on the self-defeating scale also scored higher on 
depression, passivity, and anger.  Self-defeating scale score was negatively associated with 
somatizing (F1; β = -.15, p < .05), such that individuals who scored higher on the self-defeating 
scale endorsed lower levels of somatizing. 
 The 6 CFA factors explained 40.6% of the overall variance in the schizotypal scale (R2 = 
.41, F(6,539) = 60.60, p < .01).  Schizotypal scale score was positively associated with 
antagonistic suspiciousness (F2; β = .20, p < .05) and passivity (F5; β = .26, p < .05), such that 
participants who scored higher on the schizotypal scale also scored higher on antagonistic 
suspiciousness and passivity.  The schizotypal scale was negatively associated with 
extraversion (F3; β = -.30, p < .05), meaning those who scored highly on the schizotypal scale 
scored lower on extraversion. 
 The 6 CFA factors explained 41.1% of the overall variance in the borderline scale (R2 = 
.41, F(6,539) = 61.87, p < .01).  The borderline scale was positively associated with depression 
(F4; β = .16, p < .05), passivity (F5; β = .17, p < .05), and anger (F6; β = .54, p < .05), such that 
participants who scored higher on the borderline scale endorsed higher levels of depression, 
passivity, and anger.  Borderline scale score was negatively associated with somatizing (F1; β = -
.14, p < .05), meaning individuals who scored higher on the borderline scale endorsed lower 
levels of somatizing. 
 The 6 CFA factors explained 25.5% of the overall variance in the paranoid scale (R2 = 




suspiciousness (F2; β = .29, p < .05) and anger (F6; β = .43, p < .05), meaning individuals who 
scored higher on the paranoid scale also scored higher on suspiciousness and anger.  The 
paranoid scale was negatively associated with depression (F4; β = -.30, p < .05) and passivity 
(F5; β = -.16, p < .05), such that participants who scored higher on the paranoid scale endorsed 
lower levels of depression and passivity. 
 Confirmatory Bifactor Analysis correlational analyses.  Correlations between the 
CBFA factors (i.e., the general and specific factors) and the MCMI-II Clinical Scales were 
estimated in the context of a CBFA.  Resulting model fit was good (χ² = 3335.85 (1957), 
RMSEA = .04, CFI = .91).  Table 18 includes latent factor correlations from the CBFA analysis.  
The general factor (overall psychological distress/psychopathology) was positively correlated 
with passive-aggressive (r = .60), schizotypal (r = .58), avoidant (r = .55), borderline (r = .51), 
self-defeating (r = .50), antisocial (r = .41), schizoid (r = .39), paranoid (r = .38), 
aggressive/sadistic (r = .28), and narcissistic (r = .11) PD scales.  In other words, individuals 
who endorsed overall psychological distress/psychopathology scored higher on the avoidant, 
schizoid, narcissistic, antisocial, aggressive/sadistic, passive-aggressive, self-defeating, 
schizotypal, borderline, and paranoid MCMI-II scales.  In addition, the general factor was 
negatively correlated with the compulsive (r = -.31) and histrionic (r = -.15) PD scales, meaning 
those who endorsed overall psychological distress scored lower on the histrionic and compulsive 
scales. 
 Somatizing (S1) was not positively correlated with any of the MCMI-II Clinical Scales.  
However, the factor was negatively correlated with the antisocial (r = -.22), narcissistic (r = -
.20), and aggressive/sadistic (r = -.16) PD scales.  In other words, individuals who endorsed 




 Extraversion (S2) was positively correlated with the histrionic (r = .62), narcissistic (r = 
.46), antisocial (r = .32), aggressive/sadistic (r = .27), paranoid (r = .19), schizotypal (r = .14), 
borderline (r = .14), and passive-aggressive (r = .12) PD scales.  In other words, participants who 
endorsed extraversion scored higher on the histrionic, narcissistic, antisocial, aggressive/sadistic, 
passive-aggressive, schizotypal, borderline, and paranoid scales.  Extraversion was negatively 
associated with the schizoid (r = -.51), avoidant (r = -.30), and compulsive (r = -.23) scales, such 
that participants who reported extraversion scored lower on the schizoid, avoidant, and 
compulsive scales. 
 Depression (S3) was positively correlated with the schizoid (r = .21), avoidant (r = .17), 
and self-defeating (r = .15) MCMI-II Clinical Scales.  Therefore, individuals who reported 
depression scored higher on the schizoid, avoidant, and self-defeating scales.  Depression was 
negatively correlated with the narcissistic (r = -.45), paranoid (r = -.36), histrionic (r = -.34), 
aggressive/sadistic (r = -.23), antisocial (r = -.20), and compulsive (r = -.14) scales, such that 
those who endorsed depression scored lower on the histrionic, narcissistic, antisocial, 
aggressive/sadistic, compulsive, and paranoid scales. 
 Passivity (S4) was positively correlated with the dependent (r = .69), self-defeating (r = 
.35), avoidant (r = .31), and schizoid (r = .20) PD scales, such that individuals who self-reported 
passivity scored higher on the schizoid, avoidant, dependent, and self-defeating scales.  Passivity 
was negatively associated with the narcissistic (r = -.59), aggressive/sadistic (r = -.54), antisocial 
(r = -.42), paranoid (r = -.31), and histrionic (r = -.25) scales.  In other words, participants who 





 Finally, anger (S5) was positively associated with the aggressive/sadistic (r = .45), 
passive-aggressive (r = .41), antisocial (r = .39), schizotypal (r = .36), borderline (r = .36), 
narcissistic (r = .35), histrionic (r = .32), paranoid (r = .23), and self-defeating (r = .14) scales.  
Therefore, participants who reported anger scored higher on the histrionic, narcissistic, 
antisocial, aggressive/sadistic, passive-aggressive, schizotypal, and borderline PD scales.  Anger 
was negatively associated with the dependent (r = -.32), schizoid (r = -.19), and compulsive (r = 
-.19) scales, such that those who endorsed anger scored lower on the schizoid, dependent, and 
compulsive scales. 
 Confirmatory Bifactor Analysis regression analyses.  Regression analysis was used to 
examine whether the CBFA factors were uniquely associated with MCMI-II Clinical Scales.  
The resulting model fit was good (χ² = 3335.85 (1957), RMSEA = .04, CFI = .91).  See Table 19 
for CBFA multiple regression statistics.  The 6 CBFA factors explained 53.8% of the overall 
variance in the MCMI-II schizoid scale (R2 = .54, F(6,539) = 103.25, p < .01).  Schizoid scale 
score was positively associated with overall psychological distress/psychopathology (G; β = .39, 
p < .05), depression (S3; β = .21, p < .05), and passivity (S4; β = .20, p < .05), such that 
individuals who scored higher on the schizoid scale also scored higher on overall psychological 
distress/psychopathology, depression, and passivity.  The schizoid scale was negatively 
associated with extraversion (S2; β = -.51, p < .05) and anger (S5; β = -.19, p < .05).  In other 
words, participants who scored higher on the schizoid scale endorsed lower levels of 
extraversion and anger. 
 The 6 CBFA factors explained 51.6% of the overall variance in the avoidant scale (R2 = 
.52, F(6,539) = 94.53, p < .01).  The avoidant scale was positively associated with overall 




and passivity (S4; β = .31, p < .05).  Therefore, participants who scored higher on the avoidant 
scale endorsed higher levels of overall psychological distress/psychopathology, depression, and 
passivity.  Avoidant scale score was negatively associated with extraversion (S2; β = -.30, p < 
.05), such that individuals who scored higher on the avoidant scale scored lower on extraversion. 
 The 6 CBFA factors explained 58.0% of the overall variance in the dependent scale (R2 = 
.58, F(6,539) = 122.44, p < .01).  The dependent scale was positively associated with passivity 
(S4; β = .69, p < .05), such that participants who scored highly on the dependent scale endorsed 
higher levels of passivity.  Dependent scale score was negatively associated with anger (S5; β = -
.32, p < .05).  In other words, individuals who scored higher on the dependent scale scored lower 
on anger.   
 The 6 CBFA factors explained 69.4% of the overall variance in the histrionic scale (R2 = 
.69, F(6,539) = 201.09, p < .01).  Histrionic scale score was positively associated with 
extraversion (S2; β = .62, p < .05) and anger (S5; β = .39, p < .05).  Therefore, individuals who 
scored higher on the histrionic scale also scored higher on extraversion and anger.  The histrionic 
scale was negatively associated with overall psychological distress/psychopathology (G; β = -
.15, p < .05), depression (S3; β = -.34, p < .05), and passivity (S4; β = -.25, p < .05), such that 
those who scored higher on the histrionic scale scored lower on overall psychological 
distress/psychopathology, depression, and passivity. 
 The 6 CBFA factors explained 94.2% of the overall variance in the narcissistic scale (R2 
= .94, F(6,539) = 1440.07, p < .01).  The narcissistic scale was positively associated with overall 
psychological distress/psychopathology (G; β = .11, p < .05), extraversion (S2; β = .46, p < .05), 
and anger (S5; β = .35, p < .05), meaning that individuals who scored highly on the narcissistic 




anger.  Narcissistic scale score was negatively associated with somatizing (S1; β = -.20, p < .05), 
depression (S3; β = -.45, p < .05), and passivity (S4; β = -.59, p < .05), such that participants who 
scored highly on the narcissistic scale scored lower on somatizing, depression, and passivity. 
 The 6 CBFA factors explained 68.7% of the overall variance in the antisocial scale (R2 = 
.69, F(6,539) = 194.61, p < .01).  The antisocial scale was positively associated with overall 
psychological distress/psychopathology (G; β = .41, p < .05), extraversion (S2; β = .32, p < .05), 
and anger (S5; β = .39, p < .05), meaning individuals who scored higher on the antisocial scale 
also scored higher on overall psychological distress/psychopathology, extraversion, and anger.  
Antisocial scale score was negatively associated with somatizing (S1; β = -.22, p < .05), 
depression (S3; β = -.20, p < .05), and passivity (S4; β = -.42, p < .05).  In other words, 
participants who scored higher on the antisocial scale endorsed lower levels of somatizing, 
depression, and passivity. 
 The 6 CBFA factors explained 72.4% of the overall variance in the aggressive/sadistic 
scale (R2 = .72, F(6,539) = 232.59, p < .01).  Aggressive/sadistic scale score was positively 
associated with overall psychological distress/psychopathology (G; β = .28, p < .05), 
extraversion (S2; β = .27, p < .05), and anger (S5; β = .45, p < .05), meaning individuals who 
scored higher on the aggressive/sadistic scale also scored higher on overall psychological 
distress/psychopathology, extraversion, and anger.  The aggressive/sadistic scale was negatively 
associated with somatizing (S1; β = -.15, p < .05), depression (S3; β = -.23, p < .05), and 
passivity (S4; β = -.54, p < .05).  In other words, participants who scored higher on the 
aggressive/sadistic scale endorsed lower levels of somatizing, depression, and passivity. 
 The 6 CBFA factors explained 21.7% of the overall variance in the compulsive scale (R2 




psychological distress/psychopathology (G; β = -.31, p < .05), extraversion (S2; β = -.23, p < 
.05), depression (S3; β = -.14, p < .05), and anger (S5; β = -.19, p < .05).  Therefore, individuals 
who scored higher on the compulsive scale also endorsed lower levels of overall psychological 
distress/psychopathology, extraversion, depression, and anger.  
 The 6 CBFA factors explained 55.4% of the overall variance in the passive-aggressive 
scale (R2 = .55, F(6,539) = 110.14, p < .01).  Passive-aggressive scale score was positively 
associated with overall psychological distress/psychopathology (G; β = .60, p < .05), 
extraversion (S2; β = .12, p < .05), and anger (S5; β = .41, p < .05).  In other words, participants 
who scored higher on the passive-aggressive scale also scored higher on overall psychological 
distress/psychopathology, extraversion, and anger.   
 The 6 CBFA factors explained 41.8% of the overall variance in the self-defeating scale 
(R2 = .42, F(6,539) = 63.68, p < .01).  The self-defeating scale was positively associated with 
overall psychological distress/psychopathology (G; β = .50, p < .05), depression (S3; β = .15, p < 
.05), passivity (S4; β = .35, p < .05), and anger (S5; β = .14, p < .05).  In other words, those who 
scored higher on the self-defeating scale also scored higher on overall psychological 
distress/psychopathology, depression, passivity, and anger.   
 The 6 CBFA factors explained 40.7% of the overall variance in the schizotypal scale (R2 
= .41, F(6,539) = 60.86, p < .01).  The schizotypal scale was positively associated with overall 
psychological distress/psychopathology (G; β = .58, p < .05) and passivity (S4; β = .16, p < .05), 
such that individuals who scored higher on the schizotypal scale endorsed higher levels of 
overall psychological distress/psychopathology and passivity.  Schizotypal scale score was 




.05), meaning those who scored higher on the schizotypal scale scored lower on somatizing and 
extraversion. 
 The 6 CBFA factors explained 41.9% of the overall variance in the borderline scale (R2 = 
.42, F(6,539) = 63.94, p < .01).  The borderline scale was positively associated with overall 
psychological distress/psychopathology (G; β = .51, p < .05), extraversion (S2; β = .14, p < .05), 
and anger (S5; β = .36, p < .05).  In other words, participants who scored higher on the 
borderline scale endorsed higher levels of overall psychological distress/psychopathology, 
extraversion, and anger. 
 The 6 CBFA factors explained 47.8% of the overall variance in the paranoid scale (R2 = 
.48, F(6,539) = 81.19, p < .01).  The paranoid scale was positively associated with overall 
psychological distress/psychopathology (G; β = .38, p < .05), extraversion (S2; β = .19, p < .05), 
and anger (S5; β = .23, p < .05), meaning those who scored higher on the paranoid scale also 
scored higher on overall psychological distress/psychopathology, extraversion, and anger.  
Paranoid scale score was negatively associated with depression (S3; β = -.36, p < .05) and 
passivity (S4; β = -.31, p < .05), such that participants who scored highly on the paranoid scale 
scored lower on depression and passivity. 
Aim 3 
 Omega statistics were computed based on factor loadings for the final CBFA model.  
Results are displayed in Table 20.  Omega total statistics indicated acceptable internal 
consistency reliability for the general factor (G; ω = .96), somatizing (S1; ω = .89), extraversion 
(S2; ω = .64), depression (S3; ω = .93), passivity (S4; ω = .89), and anger (S5; ω = .83).  As the 
general factor encompassed all items in the final item pool, its omega total also represents the 




omega total, and therefore may be the weakest factor in terms of clinical utility.  Omega 
hierarchical statistics indicated that extraversion (S2; ωh = .64) and anger (S5; ωh = .51) 
accounted for more of the variance in individual participant scores on the general factor than 





CHAPTER FIVE: DISCUSSION 
The current studies aimed to establish and confirm the underlying, item-level factor 
structure of the PD Spectra Scales.  Study 1 consisted of exploratory factor and bifactor analysis 
of the PD Spectra Scales item pool based on a sample of 1,030 outpatients seen at a university 
community clinic.  Study 2 included confirmatory factor and bifactor analysis of the exploratory 
models established in Study 1.  In addition, Study 2 examined criterion validity of the 
confirmatory factor models based on the MCMI-II Clinical Scales and reliability of the 
confirmatory bifactor model.  Study 2 participants were 539 inpatients and outpatients seen at a 
military clinic.   
Study 1 results showed it was possible to fit both an exploratory 6-factor model and a 6-
factor bifactor model to a reduced item pool of MMPI-2 items included in the PD Spectra Scales.  
Study 2 analyses confirmed both factor structures, indicating both models were applicable across 
diverse clinical settings.  Additionally, both models demonstrated good criterion validity, and the 
confirmatory bifactor model demonstrated good overall internal consistency.  
These findings suggest the resulting 53-item PD Spectra Scales subset may provide a 
“bridge” between traditional categorical models and dimensional models, at least for some 
aspects of psychopathology and personality functioning.  It is important to note, however, that 
neither the correlated factors nor the bifactor model supported a categorical approach to PD 
measurement.  Both models lacked factors that measured DSM-5 Section II categorical PDs, and 
instead included factors that measured personality characteristics and affective experiences (i.e., 
passivity, extraversion, and anger) and psychological symptomology (i.e., depression and 
somatizing).   The following subsections focus on a qualitative comparison of the correlated 




bifactor model’s likeness to preexisting dimensional approaches to PD measurement.  Last, 
strengths and limitations of the current studies are discussed.   
The Correlated Factors Model Versus the Bifactor Model 
 Although both a correlated factors and a bifactor model fit the data well, the emergence 
of a dominant first factor in both the initial item pool and the final item pool supports the bifactor 
model.  The antagonistic suspiciousness factor (F2) in the EFA was subsumed within the general 
factor in the EBFA.  This indicates self-report of antagonistic suspiciousness may be better 
represented within a measure of overall psychological distress than as a separate construct.  
Additionally, correlations between factors decreased significantly in the exploratory stage when 
a bifactor model was applied, indicating the variance shared between factors is better accounted 
for by a general factor.   
 Both the correlated factors and bifactor models were replicated on the Study 2 sample 
and demonstrated good model fit.  This is notable, especially given the differences in patient 
populations between the two study samples (i.e., a university community clinical sample and a 
military clinical sample).  However, it should be noted that one item was allowed to cross-load 
onto a second factor to improve model fit in the CFA, a change that was not recommended in the 
CBFA model.  In fact, modification indices reported in the CBFA model suggested no 
theoretically sound changes that would result in improved model fit.  
 Criterion validity analyses produced similar patterns of significant correlations and 
regression weights for the CFA and CBFA factors.  However, the CBFA factors explained more 
of the variance in MCMI-II Clinical Scales scores for all scales except one (i.e., the self-




scale regression (i.e., the dependent scale).  These results further support the validity of the 
bifactor model over the correlated factors model.   
 Finally, reliability (i.e., omega) statistics indicated the factors that emerged from the 
bifactor model were highly internally consistent overall.  In addition, the somatizing, depression, 
passivity, and anger factors all demonstrated high internal consistency, with internal consistency 
for the extraversion factor falling in the acceptable range.  For all of the reasons listed above, the 
remainder of this manuscript will focus on interpretations and potential applications of the 
bifactor model.   
Interpreting the Bifactor Model 
 The emergence of a general factor suggests an overarching dimension of psychological 
distress/pathology explained the majority of the variance in the item pool.  The general factor 
was characterized by a collection of depressive, paranoid, and somatizing symptomology, along 
with interpersonal problems.  All but four items in the EBFA (“like loud, fun parties,” “enjoy 
flirting,” “like being friends with pranksters,” and “worries melt in a lively crowd”) and two 
items in the CBFA (“enjoy flirting” and “like being friends with pranksters”) loaded significantly 
onto the general factor.  Items loaded highly onto the general factor from 10 PD Spectra Scales, 
indicating the factor represented a broadband measure of psychological distress/pathology.  
Criterion validity analyses also supported this notion, as the general factor demonstrated large, 
significant correlations with the MCMI-II’s avoidant, passive-aggressive, self-defeating, 
schizotypal, and borderline Clinical Scales, and significant, unique associations with scores on 
the schizoid, avoidant, histrionic, narcissistic, antisocial, aggressive/sadistic, compulsive, 




 The idea that an overarching, multifaceted measure of psychopathology is present in 
individual responses on psychological measurements is not new.  Other researchers have 
identified a general factor for psychopathology, or a p factor, through factor analysis (Caspi et 
al., 2014; Lahey, Hulle, Singh, Waldman, & Rathouz, 2011).  The p factor encompasses 
elements of all psychological disorders and might explain why psychology and medicine have 
struggled to identify precise, homogeneous causes, biomarkers, and treatments for most mental 
disorders. 
  The specific factors that emerged in the bifactor model reflected dimensions of 
somatizing (S1), extraversion (S2), depression (S3), passivity (S4), and anger (S5).  Interestingly, 
the factors represented a mixture of psychological symptoms (i.e., somatizing and depression) 
and personality characteristics/affective experiences (i.e., extraversion, passivity, and anger).  
Criterion validity analyses indicated the somatizing factor was not closely related to any of the 
MCMI-II Clinical Scales, which was expected given that the Clinical Scales do not include a 
somatizing scale.   
 Alternatively, extraversion correlated highly with the histrionic scale and proved to be a 
unique predictor of histrionic, narcissistic, and antisocial MCMI-II Clinical Scale scores.  The 
externalizing nature of these Cluster B PDs supports the validity of this finding.  Notably, the 
regression of the borderline scale on the CBFA factors revealed that the general factor accounted 
for the vast majority of the variance in borderline scale score, rather than the extraversion factor; 
this finding is supportive of arguments that borderline PD is better characterized as a measure of 
overall distress and maladaptive personality functioning rather than as a discrete disorder (Sharp 
et al., 2015).  As would be expected theoretically, extraversion was most inversely related to 




 Criterion validity analyses revealed weaker correlations and smaller regression weights 
for MCMI-II Clinical Scales for the depression factor compared to the extraversion factor.  
Depression was positively associated with and uniquely predicted schizoid and avoidant scale 
scores, and was inversely related to paranoid, aggressive/sadistic, antisocial, narcissistic, and 
histrionic scores.  These findings support the validity of the factor for the following reasons: 
depression is characterized as an internalized form of psychopathology (Gorka, Burkhouse, 
Afshar, & Phan, 2017), avoidant PD is associated with internalizing symptomology (Harford et 
al., 2013), and antisocial and histrionic PDs are often comorbid with externalizing disorders 
rather than internalizing disorders (Harford et al., 2013). 
 The passivity factor displayed similar patterns of criterion validity to the depression 
factor, likely due to the shared element of internalization in the two constructs.  However, 
passivity was also highly, positively related to MCMI-II dependent scale score.  This finding 
reflects the unique interpersonal orientation of passivity that is not shared with depression.  
Whereas passivity is characterized by a view of others as more competent than oneself and the 
tendency to defer to others (Gore, Presnall, Miller, Lynam, & Widiger, 2012), depression is 
associated with isolation from interpersonal interactions (American Psychiatric Association, 
2013). 
 Finally, anger was positively related to aggressive/sadistic and passive-aggressive 
MCMI-II Clinical Scale scores, and uniquely predicted histrionic, narcissistic, antisocial, and 
borderline scale scores.  These findings are congruent with the externalizing element of anger 
expression.  Additionally, anger was a negative predictor of dependent scale score, which further 




Overlap with the MMPI-2 Restructured Clinical (RC) Scales 
Comparison between the CBFA structure and the MMPI-2 Restructured Clinical (RC) 
Scales is warranted in interpreting the bifactor model, given that the RC Scales are the product of 
factor analysis on the entire MMPI-2 item pool (Ben-Porath, 2008).  In addition, the constructs 
reflected in the CBFA model matched that of some of the RC Scales.  The RC scales are: 
demoralization (RCd), somatic complaints (RC1), low positive emotions (RC2), cynicism (RC3), 
antisocial behavior (RC4), ideas of persecution (RC6), dysfunctional negative emotions (RC7), 
aberrant experiences (RC8), and hypomanic activation (RC9).  At first glance, the conceptual 
underpinnings of the somatic complaints (RC1), low positive emotions (RC2), and ideas of 
persecution (RC6) scales seemed particularly reflective of scale constructs and item content 
present in the CBFA.  However, when item overlap was computed between the CBFA factors 
and all RC scales, 36 out of 54 (66.7%) of the item membership comparisons showed no item 
overlap (see Tables 21 and 22).  Items that loaded at least .30 onto the general factor overlapped 
just 2% (1 item) with demoralization (RCd; “numbness on skin”), low positive emotions (RC2; 
“burning/tingling sensation all over”), and cynicism (RC3; “someone is out to get me”); 4% (2 
items) with somatic complaints (RC1; “frequent stomach aches” and “feeling of a tight band 
around head”) and ideas of persecution (RC6; “uncaring about what happens to me” and “most 
people will act unfairly to get ahead”); and 6% (3 items) with dysfunctional negative emotions 
(RC7; “it is easy to make me cry”, “easily embarrassed”, and “frequent suicidal thoughts”) and 
hypomanic activation (RC9; “feel important” loaded negatively; “fullness in head/nose most of 
the time” and “more likely to be a wallflower at a party” loaded positively).  The content of the 
overlapping items highlight the elements of negative affectivity, interpersonal mistrust and 




 Next, the specific factors from the bifactor model were compared to the RC Scales.  
Items that loaded onto the somatizing factor overlapped 20% (2 items) with somatic complaints 
(RC1; “frequent stomach aches” and “feeling of a tight band around head”) and hypomanic 
activation (RC9; “fullness in head/nose most of the time” and “no hay fever/asthma”), and 10% 
(1 item) with demoralization (RCd; “numbness on skin”) and low positive emotions (RC2; 
“burning/tingling sensation all over”).  This indicates that the somatizing factor tapped constructs 
also included within somatic complaints, hypomanic activation, demoralization, and low positive 
emotions.  However, item content all reflected somatic symptoms and therefore support the 
conceptual validity of the somatizing factor.   
The extraversion factor items overlapped 20% (2 items) with hypomanic activation (RC9; 
“like being friends with pranksters” and “more like a wallflower at a party”) and 10% (1 item) 
with somatic complaints (RC1; “enjoy flirting”), indicating some shared construct tapping.  
However, “enjoy flirting” loaded positively onto the extraversion factor and negatively on 
somatic complaints (RC1).  This suggests the absence of somatic complaints is reflected in the 
extraversion factor. 
 The depression factor items overlapped 11% with ideas of persecution (RC6), 
dysfunctional negative emotions (RC7), and hypomanic activation (RC9; 1 item each).  
Construct overlap for depression is unsurprising for the first two RC scales, given the conceptual 
similarity between depression, ideas of persecution, and dysfunctional negative emotions.  The 
item content (i.e., “uncaring about what happens to me” and “frequent suicidal thoughts”) is also 
supportive of the construct of depression.  The item shared between the depression factor and 
hypomanic activation (RC9; “feel important”) loaded negatively onto the depression factor and 




between low self regard seen commonly in depressed individuals and high self regard seen in 
hypomanic individuals (American Psychiatric Association, 2013).   
 The passivity factor demonstrated the highest proportion of item overlap with an RC 
Scale: 25% (2 items) with dysfunctional negative emotions (RC7).  The two items shared 
between the passivity factor and dysfunctional negative emotions (RC7; “it is easy to make me 
cry” and “easily embarrassed”) highlight sensitivity to the interpersonal environment.  
Conversely, only one anger factor item (14% of the factor items) overlapped with an RC Scale; 
the shared item was found on cynicism (RC3).  The item (“anger easily but calm down quickly”) 
highlighted the angry element that is found in cynicism (RC3), but represented more fully in the 
anger factor. 
 Therefore, consideration of conceptual and item overlap between the general and specific 
factors from the bifactor model and the RC Scales supports the bifactor structure’s conceptual 
uniqueness from the RC Scales.  Although item overlap was observed between the factors and 
individual RC Scales, large conceptual differences between the RC Scales and the factors 
remained.  Additionally, item overlap was minimal between the bifactor model factors and the 
RC Scales. 
Comparing the Bifactor Model to Other Dimensional Models of PD 
As elucidated in the introduction to the current studies, past research has advocated for 
the use of dimensional models to classify PDs.  Given that the results of the current studies 
supported a dimensional structure for the reduced PD Spectra Scales item pool, comparison to 
existing dimensional models is warranted.  As such, the following subsections compare the 




The Bifactor Model and the AMPD.  DSM-5’s AMPD Criterion A consists of 
dimensional ratings of an individual’s level of impairment in two domains: self (broken up into 
identity and self-direction dimensions) and interpersonal (empathy and intimacy dimensions; 
American Psychiatric Association, 2013).  Criterion B allows for assignment of maladaptive 
personality traits (American Psychiatric Association, 2013).  The bifactor model showed some 
conceptual similarities to the AMPD, but the shared conceptual grounding of the two models was 
not as complete as was hypothesized.   
First, the general factor that emerged in the bifactor model showed some similarities to 
AMPD Criterion A.  In regard to the self domain of Criterion A, concepts of emotion regulation 
ability and stability of self-esteem from the identity dimension were reflected in items that 
loaded well onto the general factor (i.e., “difficult to anger,” “intense anger,” “never lose self 
control,” “feel important,” “changeable opinions,” “vulnerable to criticism,” “nervous about 
important decisions, “easily embarrassed,” “easily defeated in arguments”).  However, the 
general factor did not include any items that tapped concepts found in the AMPD’s self-direction 
dimension.   
 Alternatively, both dimensions of the interpersonal domain of Criterion A, empathy and 
intimacy, were reflected in the general factor.  Specifically, items that tapped tolerance of 
differing perspectives (i.e., “frequent serious arguments with close others”), comprehension of 
others’ experiences and motivations (i.e., “people are plotting against me,” “most people will act 
unfairly to get ahead,” “someone is out to get me,” “people dislike helping others,” “people are 
unkind”), and capacity for closeness (i.e., “happiest alone,” “enjoy just being with other people,” 
“avoid crowds”) were all present in items that loaded highly onto the general factor.  However, 




tapping somatic concerns and depressive symptomology also loaded highly onto the general 
factor, and these concepts are not included in Criterion A.   
 Criterion B of the AMPD consists of assignment of any number of the 25 listed 
maladaptive personality traits.  The personality traits are organized into five categories: negative 
affectivity, detachment, antagonism, disinhibition, and psychoticism.  Consideration of AMPD 
Criterion B and the specific factors in the bifactor model revealed some conceptual overlap.  The 
depression factor was related to the Criterion B domain of negative affectivity, as were the anger 
and passivity factors.  Specifically, the trait facets of emotional lability, submissiveness, 
hostility, and depressivity were present in the aforementioned factors.  Additionally, the 
detachment domain was mirrored by the extraversion factor, as detachment and extraversion 
represent opposite poles of the same personality domain.  However, the antagonism, 
disinhibition, and psychoticism domains were not reflected in the specific factors.  Additionally, 
as mentioned above, the somatizing factor was not conceptually related to Criterion B.  The lack 
of conceptual overlap between the Criterion B categories and the bifactor model factors further 
indicates that the bifactor model reflects only portions of the AMPD.  Therefore, it is necessary 
to consider other dimensional models in interpreting the bifactor structure of the PD Spectra 
Scales. 
 Considering the HiTOP Model.  Another dimensional model of psychopathology, the 
Hierarchical Taxonomy of Psychopathology (HiTOP Model; Kotov et al., 2017), deserves 
mention given its conceptual similarities with the bifactor structure that emerged in the current 
study.  The HiTOP Model was developed by a group of personality researchers through review 
of quantitative research and organization of factor analytic findings into “superspectra”, spectra, 




superspectra domain represents a higher-order dimension, known as a p factor (mentioned above 
in the interpretation of the current studies’ general factor), as the six underlying spectra are 
positively correlated with one another.  The six spectra included in the HiTOP Model are: 
somatoform, internalizing, thought disorder, disinhibited externalizing, antagonistic 
externalizing, and detachment.   
 First, the p factor from the HiTOP model shares conceptual similarities with the general 
factor that emerged in the current study, as both account for the correlations amongst the 
underlying factors/spectra and represent a range of psychopathology and personality 
characteristics.  Second, the relationships between the HiTOP spectra and the current studies’ 
specific factors were mixed.  The somatizing factor was conceptually related to the somatoform 
spectrum, as the following HiTOP components were represented in the somatizing factor: 
conversion, somatization, malaise, head pain, and gastrointestinal issues.  The only component of 
the somatoform spectrum that was not represented within the 53 PD Spectra Scale items was the 
cognitive component. 
 Additionally, the extraversion factor shares conceptual underpinnings with the HiTOP 
detachment spectrum.  Specifically, the following detachment traits were reflected in the 
extraversion factor: disaffiliativeness, withdrawal, and attention seeking.  The detachment traits 
of anhedonia, depressivity, intimacy avoidance, suspiciousness, and interpersonal passivity were 
not present in the extraversion factor, although some elements of these could be found in the 
depression (i.e., anhedonia, depressivity) and passivity (i.e., interpersonal passivity) factors and 
in the general factor (i.e., suspiciousness). 
 Lastly, the depression factor showed conceptual similarities to the HiTOP internalizing 




distress components of anhedonia, suicidality, and numbing.  However, this leaves a number of 
internalizing spectrum distress components and all fear components and traits untapped by the 
PD Spectra Scales items.   
 The thought disorder, disinhibited externalizing, and antagonistic externalizing HiTOP 
spectra were not tapped by any of the 53 PD Spectra Scale items.  In sum, while it does not 
match perfectly with the bifactor model, the conceptual similarities shared between the HiTOP 
Model and the bifactor model fill in some of the differences observed between the bifactor model 
and the AMPD (i.e., elements of the general factor, the somatizing factor).  In fact, the PD 
Spectra Scale bifactor model seems to represent a “mash up” of parts of the AMPD and HiTOP.   
Strengths and Limitations of the Current Studies 
 The present studies were strengthened by the confirmation of the exploratory factor 
structures established in Study 1 on a separate sample from a military clinical setting in Study 2.  
The success of the Study 2 confirmatory analyses suggests that the resulting bifactor model may 
be generalizable across different clinical settings.  Another strength of the current studies was the 
inclusion of criterion validity analyses based on the MCMI-II Clinical Scales and reliability 
analyses, both of which provided support for the bifactor model.  Third, an important benefit of 
the current studies is that the bifactor structure can be applied to a standard administration of the 
MMPI-2 by utilizing the database export function and rescoring the 53 items included in the 
bifactor structure accordingly.  Thus, any clinician or researcher with access to the MMPI-2 can 
utilize the bifactor model in their work.  
An important limitation of the current study is its sole basis on self-report data of 
personality and psychological functioning.  It is possible that study participants provided a biased 




syntonic (Alliances of Psychoanalytic Organizations, 2017).  However, a prior study by Samuel 
et al. (2011) indicated that self-reported PD symptoms show higher temporal stability compared 
to those assessed by an interviewer, suggesting self-report may be a valid report form for PD 
symptoms.    
 Another limitation of the current studies is that the PD Spectra Scale item pool was 
significantly reduced in the course of the factor analytic procedure (i.e., from 220 to just 53 
items), resulting in a 75.5% loss of items.  Such a significant loss of items from the initial item 
pool indicates the original PD Spectra Scales were not robust when subjected to factor analysis.  
The resulting bifactor model is still theoretically interesting and offers clinical utility, but linking 
the resulting model back to the original PD Spectra Scales is difficult given the substantial loss 
of items.  However, the factor structure that emerged fit the data well and the factors were 
associated in the expected directions with other measurements of PD symptomology (i.e., 
MCMI-II Clinical Scales).  Still, although a level of criterion validity was established using the 
MCMI-II, further study is needed to expand the criterion validity and determine the construct 
validity of the bifactor model.  Future studies would be well advised to compare the bifactor 
structure to more modern, dimensional measures of PD, such as the PID-5.    
Caution should be taken when interpreting the results of the current studies, as only one 
measure (the MMPI-2) was considered, and thorough PD diagnosis should be comprehensive.  
Clinical observation and judgment are often touted as important contributions to competent PD 
diagnosis (e.g., Alliances of Psychoanalytic Organizations, 2017; American Psychiatric 
Association, 2013; Hopwood et al., 2011; Morey et al., 2014), and interviewing individuals close 
to the patient can be helpful when symptoms are ego-syntonic.  Use of performance-based 




interviews/observations to account for the lack of insight often present in those with PDs 
(Bornstein, 2014).  In other words, real-world diagnosis of PDs should look different from the 
methodology of the current studies, as the present research was focused on just one element of 
PD diagnosis.   
Relatedly, despite the improved clinical and diagnostic utility of the dimensional 
approach, even a dimensional model for PDs cannot adequately capture the diversity of human 
experience and psychological presentation.  All such models will leave clinicians who engage in 
depth work with their patients wanting.  Nancy McWilliams and Jonathan Shedler describe the 
dilemma well in the PDM-2 (Alliances of Psychoanalytic Organizations, 2017, p. 27), so they are 
given the last word on the matter: 
 There are many ways to distinguish psychologically between one person and another.  All 
 of them are, of course, oversimplifications.  Any clinician who gets to know a patient 
 intimately finds that over time, that person no longer seems to fit a clear-cut diagnostic 
 construct; the person’s individuality eventually becomes more salient...[P]ersonality 
 syndromes are “fuzzy sets” or continua lacking clear-cut boundaries, and the degree to 
 which any personality syndrome applies is always a dimension ranging from inapplicable 






CHAPTER SIX: CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
 The results of the current studies offer a dimensional measurement of psychopathology 
and personality functioning based on a bifactor model made up of 53 existing MMPI-2 items.  
The model consists of a general factor that measures overall psychological 
distress/psychopathology and five specific factors measuring the psychological 
syndromes/personality dimensions of somatizing, extraversion, depression, passivity, and anger.  
The bifactor structure proved reliable and its criterion validity was supported.  As such, scoring 
MMPI-2 responses using the bifactor model offered here may prove clinically useful to 
clinicians in understanding the personality functioning of their patients.   
 Perhaps most importantly, the results of the current studies support a dimensional 
conceptualization of personality over a categorical approach.  Dimensional modeling encourages 
mental health professionals to approach their patients more compassionately and has the 
potential to decrease the overall stigmatization of PDs.  In fact, use of the AMPD and other 
dimensional models for PDs arguably constitutes a humanitarian and mental health advocacy 
approach to diagnosis and treatment, because use of dimensions affirms that there is no clear line 
between normality and abnormality when it comes to personality.  Work in this area should 
continue if as psychologists we are to fulfill our ethical duty to the individuals who allow us to 
bear witness to their suffering, their triumphs, and everything in between. 
Future Directions 
 Future research should expand upon the criterion validity analyses conducted in Study 2 
and establish construct validity for the bifactor model.  Comparison of the PD Spectra Scales 




informative in further understanding the validity of the bifactor structure.  Construct validity 
should be established using other report sources, such as clinician rating systems (e.g., the 
SCORS-G, Hilsenroth, Stein, & Pinsker, 2007) and projective measures (e.g., R-PAS, Meyer, 
2011; TAT, Murray, 1943).  These analyses will hopefully shed more light on interpretation of 
the PD Spectra Scales bifactor model in the context of other dimensional models for PD.  In 
addition, the bifactor model should be tested on other clinical and normative populations.  
Continued study of the model’s generalizability to different populations will further determine its 
potential clinical utility and could lead to development of norms for the bifactor measurement of 
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 Appendix 1: PD Spectra Scales Items 
Paranoid Scale 
42 Others have prevented my success (T)  
99 Others are after me (T) 
124 Suspicious of kindness (T) 
138 People are plotting against me (T) 
225 Actions are misunderstood by others (T)  
241 Trusting others is dangerous (T) 
259 People are talking about me (T) 
286 People dislike helping others (T)  
314 No enemies (F) 
315 Friendliness is suspicious (T) 
333 People insult me (T) 
358 Jealous of my ideas (T)  
403 People think I’m out to get them when I’m trying to help (T)  
445 My managers have stepped on their subordinates to get ahead (T) 
484 People are unkind (T)  
549 Always being tested (T) 
 
Schizotypal Scale 
32 Strange experiences (T) 
72 Soul leaves body (T) 




198 Hear voices (T) 
298 Strange smells (T) 
307 Hear too well (T) 
311 Unreality (T) 
316 Strange thoughts (T) 
319 Strange sounds (T) 
361 Mind control (T)  
427 No visions (F) 
448 Secret imaginary life (T) 
466 Telepathy of others (T) 
508 Telepathy of self (T) 
551 Hear thoughts out loud (T) 
 
Avoidant Scale 
46 Avoid talking to old friends (T) 
79 Teasing doesn’t bother me (F) 
161 Often try to hide embarrassment (T) 
167 Difficulty talking to new people (T) 
178 Sweat when embarrassed (T) 
185 Wish less shy (T) 
243 Difficulty choosing topic in group of people (T) 
262 Would not be embarrassed to state opinion in a group (F) 




275 Difficulty talking in class (T) 
289 Easily embarrassed (T) 
310 Cross streets to avoid people (T) 
321 Comfortable entering a room of people (F) 
335 Not self-conscious (F) 
337 More likely to be a wallflower at a party (T)  
342 Speak with strangers on public transit (F)  
360 Like meeting new people (F) 
375 Personal questions are nerve-wracking (T) 
446 Difficulty standing up for self (T) 
 
Dependent Scale 
70 Easily defeated in arguments (T) 
127 Hurt by critique (T)  
129 Model behavior after that of others (T) 
348 Wish to be a child (T) 
368 Avoid dealing with difficulties (T) 
421 Vulnerable to criticism (T) 
457 Changeable opinions (T) 
491 Helpless making decisions (T) 
503 Passive/follower (T) 
509 Nervous about important decisions (T) 





9 Interesting things in life (F) 
22 Misunderstood (T) 
38 Unable to get going on tasks (T) 
52 Life lived wrongly (T) 
56 Wish to be happy as others (T) 
75 Life is usually worthwhile (F) 
92 Uncaring about what happens to me (T) 
130 Uselessness (T) 
148 Never felt better (F) 
196 Often worries (T)  
273 Often straining (T) 
301 Near constant anxiety (T) 
303 Most of the time I wish I were dead (T)  
317 Anxious/upset to leave home (T)  
339 Problems pile up (T) 
364 Gives up quickly (T)  
377 Unhappy with self (T) 
388 Infrequently sad (F) 
400 Uncaring (T) 
408 Difficulty letting go of disappointment (T) 
411 Self is no good (T) 




450 Unable to do things well (T) 
454 Hopeless future (T)  
485 Not as good as others (T) 
516 Empty/meaningless life (T)  
517 Difficulty keeping jobs (T)  
539 Loss of desire to make things better (T) 
546 Thoughts of death and afterlife (T) 
556 Financial worries (T)  
 
Histrionic Scale 
86 Like loud, fun parties (T) 
112 Enjoy drama (T) 
153 Like knowing important people (T)  
158 Uncomfortable pulling stunts at parties (F) 
169 Creates excitement when bored (T) 
189 Enjoy flirting (T) 
207 Wants multiple club memberships (T) 
231 Like being friends with pranksters (T)  
242 Excitable (T) 
244 Excitement improves mood (T)  
340 Enjoy dances (T) 
353 Enjoy just being with other people (T) 




363 Worries melt in a lively crowd (T) 
370 Enjoy parties (T) 
456 Want pricey clothes (T) 
552 Trust will always be cared for (T)  
 
Antisocial Scale 
27 Payback when wronged (T)  
35 History of stealing (T) 
41 Lying (T) 
66 Don’t like laws (T) 
81 Most people would lie to do better than others (T) 
84 History of school suspension (T) 
100 Don’t take risks for fun (F) 
105 Sometimes sent to principal (T) 
110 Most people will act unfairly to get ahead (T)  
123 Would sneak into a movie (T) 
134 Wants to start physical fights (T) 
240 Can’t resist stealing (T) 
250 Entertained by others’ criminal activities (T) 
266 No illegal activity (F) 
269 Best to come up with a story if caught (T) 
284 People lie to get out of things (T) 




344 Likes gambling (T) 
412 History of school truancy (T) 
418 Bending laws is okay (T) 
429 No history of illicit drug use (F) 
431 Bad grades in school (T) 
432 Selective truth telling to protect self (T) 
540 Broken things when drunk (T)  
548 Physically attacked others when drunk (T) 
 
Somatizing Scale 
3 Wake up rested (F) 
28 Frequent stomach aches (T) 
33 Infrequent health worries (F) 
39 Sleeps poorly (T) 
45 As healthy as friends (F) 
53 Burning/tingling sensation all over body (T) 
57 Never feel pain in back of neck (F) 
91 No muscle twitching (F) 
97 Fullness in head/nose most of the time (T) 
101 Feeling of a tight band around head (T) 
111 Frequent stomach trouble (T) 
118 Not worried about germs (F) 




149 Tenderness atop head (T) 
165 Okay memory (F) 
177 No clumsiness in hands (F) 
181 No hay fever/asthma (F) 
208 Infrequent heart/lung symptoms (F) 
247 Numbness on skin (T) 
295 No paralysis/muscle weakness (F) 
536 Upset leads to headache (T) 
 
Borderline Scale 
23 Uncontrollable crying and laughing (T)  
37 Feel like breaking things (T) 
63 Thick-skinned (F)  
82 Often regret actions (T)  
116 Unexplainable irritability (T)  
146 It is easy to make me cry (T) 
213 Anger easily but calm down quickly (T) 
215 Frequent brooding (T) 
256 Hate family at times (T) 
271 Intense feelings (T) 
285 Heightened sensitivity (T) 
288 Relatives find fault with me (T)  




328 Unpleasant thoughts linger (T) 
372 Difficult to anger (F) 
382 Frequent serious arguments with close others (T) 
386 Physically removed self to avoid regret (T)  
389 Hotheaded (T) 
405 Generally calm (F) 
430 Regret being irritated often (T) 
442 Unreasonable worries (T)  
444 High-strung (T) 
502 Harmful habits (T)  
513 All-encompassing anger (T) 
520 Recent suicidal thoughts (T) 
530 Self injury (T)  
542 Intense anger (T) 
564 Never lose self control (F) 
 
Obsessive Compulsive Scale 
55 Perseverate (T)  
87 Unable to make up mind - too many options (T) 
135 Unable to make up mind - lost opportunities (T)  
136 Impatient when interrupted (T) 
212 Principled (T) 




313 Obsessive counting (T) 
346 Just as good as experts (T) 
356 Hard to set aside projects (T) 
410 Verbally address small social faux pas (T) 
423 Persistent to win arguments (T) 
461 Don’t like to be rushed (T) 
535 Angry when others take too long (T) 
547 Hoarding (T) 
 
Narcissistic Scale  
61 Feel important (T) 
73 Lack confidence (F) 
109 As good as others (T) 
120 Stand up for morals (T)  
157 Not concerned with others’ opinions (T) 
239 Completely confident (T) 
318 Expect to succeed (T) 
326 History of giving up when not good at something (F) 
345 Could help the world a lot (T) 
350 Would be a good leader (T) 
365 Want others to know where I stand (T) 
437 Directly correct others (T)  




460 Last one to give up (T) 
521 Enjoys leading and delegating (T) 
 
Schizoid Scale 
12 Satisfactory sex life (F)  
49 Very social (F) 
280 Makes friends easily (F)  
281 Dislike being around others (T) 
349 Happiest alone (T) 
367 Avoid crowds (T)  
391 Unable to open up to others (T) 
479 Difficult to get to know (T) 





Appendix 2: Tables and Figures 
Table 1 
Study 1 PD Spectra Scale Items Frequencies (N = 1,030) 
Item number True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
3 690 67.0 339 32.9 1 0.1 
9 420 40.8 607 58.9 3 0.3 
12 489 47.5 522 50.7 19 1.8 
22 347 33.7 679 65.9 4 0.4 
23 252 24.5 776 75.3 2 0.2 
27 228 22.1 801 77.8 1 0.1 
28 291 28.3 739 71.7 0 0.0 
32 355 34.5 673 65.3 2 0.2 
33 603 58.5 427 41.5 0 0.0 
35 360 35.0 669 65.0 1 0.1 
37 377 36.6 653 63.4 0 0.0 
38 581 56.4 448 43.5 1 0.1 
39 373 36.2 652 63.3 5 0.5 
41 592 57.5 434 42.1 4 0.4 
42 71 6.9 958 93.0 1 0.1 
45 341 33.1 688 66.8 1 0.1 
46 452 43.9 578 56.1 0 0.0 
49 389 37.8 637 61.8 4 0.4 
52 315 30.6 710 68.9 5 0.5 
53 301 29.2 727 70.6 2 0.2 
55 449 43.6 576 55.9 5 0.5 
56 656 63.7 373 36.2 1 0.1 
57 455 44.2 574 55.7 1 0.1 
61 603 58.5 422 41.0 5 0.5 
63 652 63.3 376 36.5 2 0.2 
66 67 6.5 960 93.2 3 0.3 
70 305 29.6 720 69.9 5 0.5 
72 47 4.6 980 95.1 3 0.3 
73 459 44.6 569 55.2 2 0.2 
75 188 18.3 840 81.6 2 0.2 
79 618 60.0 410 39.8 2 0.2 
81 663 64.4 366 35.5 1 0.1 
82 370 35.9 659 64.0 1 0.1 
84 220 21.4 809 78.5 1 0.1 
86 469 45.5 559 54.3 2 0.2 
87 672 65.2 352 34.2 6 0.6 
91 290 28.2 737 71.6 3 0.3 
92 195 18.9 833 80.9 2 0.2 
97 173 16.8 850 82.5 7 0.7 
99 111 10.8 917 89.0 2 0.2 




Table 1. Continued.       
Item number  True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
101 114 11.1 915 88.8 1 0.1 
105 287 27.9 743 72.1 0 0.0 
109 826 80.2 201 19.5 3 0.3 
110 644 62.5 384 37.3 2 0.2 
111 214 20.8 816 79.2 0 0.0 
112 234 22.7 788 76.5 8 0.8 
116 517 50.2 513 49.8 0 0.0 
118 547 53.1 483 46.9 0 0.0 
120 807 78.3 219 21.3 4 0.4 
123 327 31.7 698 67.8 5 0.5 
124 469 45.5 555 53.9 6 0.6 
127 520 50.5 507 49.2 3 0.3 
129 318 30.9 708 68.7 4 0.4 
130 619 60.1 408 39.6 3 0.3 
134 193 18.7 834 81.0 3 0.3 
135 522 50.7 505 49.0 3 0.3 
136 437 42.4 587 57.0 6 0.6 
138 68 6.6 955 92.7 7 0.7 
141 287 27.9 739 71.7 4 0.4 
146 402 39.0 627 60.9 1 0.1 
148 791 76.8 236 22.9 3 0.3 
149 124 12.0 906 88.0 0 0.0 
153 434 42.1 594 57.7 2 0.2 
157 286 27.8 741 71.9 3 0.3 
158 432 41.9 584 56.7 14 1.4 
161 333 32.3 691 67.1 6 0.6 
165 363 35.2 666 64.7 1 0.1 
167 410 39.8 620 60.2 0 0.0 
168 196 19.0 831 80.7 3 0.3 
169 361 35.0 668 64.9 1 0.1 
177 238 23.1 792 76.9 0 0.0 
178 352 34.2 677 65.7 1 0.1 
181 322 31.3 708 68.7 0 0.0 
185 454 44.1 574 55.7 2 0.2 
189 644 62.5 383 37.2 3 0.3 
196 790 76.7 240 23.3 0 0.0 
198 27 2.6 1002 97.3 1 0.1 
207 387 37.6 642 62.3 1 0.1 
208 452 43.9 576 55.9 2 0.2 
212 300 29.1 724 70.3 6 0.6 
213 461 44.8 569 55.2 0 0.0 
215 365 35.4 638 61.9 27 2.6 
225 484 47.0 546 53.0 0 0.0 




Table 1. Continued.       
Item number  True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
239 235 22.8 795 77.2 0 0.0 
240 59 5.7 971 94.3 0 0.0 
241 357 34.7 672 65.2 1 0.1 
242 457 44.4 572 55.5 1 0.1 
243 470 45.6 560 54.4 0 0.0 
244 571 55.4 459 44.6 0 0.0 
247 125 12.1 904 87.8 1 0.1 
250 283 27.5 745 72.3 2 0.2 
256 298 28.9 731 71.0 1 0.1 
259 338 32.8 689 66.9 3 0.3 
262 295 28.6 735 71.4 0 0.0 
265 457 44.4 573 55.6 0 0.0 
266 351 34.1 678 65.8 1 0.1 
269 269 26.1 759 73.7 2 0.2 
271 572 55.5 454 44.1 4 0.4 
273 452 43.9 576 55.9 2 0.2 
275 544 52.8 485 47.1 1 0.1 
280 356 34.6 671 65.1 3 0.3 
281 134 13.0 894 86.8 2 0.2 
284 578 56.1 450 43.7 2 0.2 
285 590 57.3 439 42.6 1 0.1 
286 369 35.8 658 63.9 3 0.3 
288 268 26.0 761 73.9 1 0.1 
289 453 44.0 577 56.0 0 0.0 
295 213 20.7 816 79.2 1 0.1 
298 167 16.2 862 83.7 1 0.1 
301 577 56.0 451 43.8 2 0.2 
302 496 48.2 532 51.7 2 0.2 
303 84 8.2 943 91.6 3 0.3 
307 159 15.4 871 85.6 0 0.0 
309 474 46.0 556 54.0 0 0.0 
310 183 17.8 846 82.1 1 0.1 
311 124 12.0 905 87.9 1 0.1 
313 245 23.8 784 76.1 1 0.1 
314 173 16.8 856 83.1 1 0.1 
315 522 50.7 508 49.3 0 0.0 
316 334 32.4 696 67.6 0 0.0 
317 121 11.7 909 88.3 0 0.0 
318 824 80.0 206 20.0 0 0.0 
319 56 5.4 974 94.6 0 0.0 
321 433 42.0 596 57.9 1 0.1 
324 73 7.1 957 92.9 0 0.0 
326 550 53.4 479 46.5 1 0.1 




Table 1. Continued.       
Item number  True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
333 161 15.6 869 84.4 0 0.0 
335 543 52.7 480 46.6 7 0.7 
337 505 49.0 525 51.0 0 0.0 
339 704 68.3 325 31.6 1 0.1 
340 401 38.9 626 60.8 3 0.3 
342 669 65.0 359 34.9 2 0.2 
344 316 30.7 712 69.1 2 0.2 
345 802 77.9 224 21.7 4 0.4 
346 475 46.1 553 53.7 2 0.2 
348 430 41.7 599 58.2 1 0.1 
349 129 12.5 898 87.2 3 0.3 
350 603 58.5 421 40.9 6 0.6 
353 698 67.8 327 31.7 5 0.5 
356 373 36.2 654 63.5 3 0.3 
358 165 16.0 863 83.8 2 0.2 
359 597 58.0 432 41.9 1 0.1 
360 237 23.0 792 76.9 1 0.1 
361 42 4.1 987 95.8 1 0.1 
363 556 54.0 471 45.7 3 0.3 
364 419 40.7 610 59.2 1 0.1 
365 762 74.0 265 25.7 3 0.3 
367 376 36.5 653 63.4 1 0.1 
368 345 33.5 683 66.3 2 0.2 
370 677 65.7 350 34.0 3 0.3 
372 382 37.1 647 62.8 1 0.1 
375 414 40.2 614 59.6 2 0.2 
377 574 55.7 454 44.1 2 0.2 
382 299 29.0 731 71.0 0 0.0 
386 545 52.9 485 47.1 0 0.0 
388 625 60.7 404 39.2 1 0.1 
389 243 23.6 786 76.3 1 0.1 
391 388 37.7 639 62.0 3 0.3 
400 363 35.2 666 64.7 1 0.1 
403 524 50.9 504 48.9 2 0.2 
405 368 35.7 659 64.0 3 0.3 
408 514 49.9 512 49.7 4 0.4 
410 301 29.2 727 70.6 2 0.2 
411 497 48.3 531 51.6 2 0.2 
412 228 22.1 801 77.8 1 0.1 
415 528 51.3 499 48.4 3 0.3 
418 439 42.6 587 57.0 4 0.4 
421 313 30.4 716 69.5 1 0.1 
423 422 41.0 605 58.7 3 0.3 




Table 1. Continued.       
Item number  True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
429 343 33.3 687 66.7 0 0.0 
430 492 47.8 538 52.2 0 0.0 
431 129 12.5 900 87.4 1 0.1 
432 260 25.2 770 74.8 0 0.0 
437 628 61.0 401 38.9 1 0.1 
442 703 68.3 326 31.7 1 0.1 
444 397 38.5 626 60.8 7 0.7 
445 378 36.7 647 62.8 5 0.5 
446 401 38.9 628 61.0 1 0.1 
448 239 23.2 790 76.7 1 0.1 
450 107 10.4 922 89.5 1 0.1 
452 552 53.6 475 46.1 3 0.3 
454 223 21.7 805 78.2 2 0.2 
456 549 53.3 477 46.3 4 0.4 
457 281 27.3 746 72.4 3 0.3 
460 668 64.9 358 34.8 4 0.4 
461 662 64.3 367 35.6 1 0.1 
466 262 25.4 767 74.5 1 0.1 
479 453 44.0 573 55.6 4 0.4 
480 521 50.6 505 49.0 4 0.4 
484 77 7.5 952 92.4 1 0.1 
485 485 47.1 544 52.8 1 0.1 
491 395 38.3 630 61.2 5 0.5 
502 293 28.4 736 71.5 1 0.1 
503 328 31.8 700 68.0 2 0.2 
508 117 11.4 913 88.6 0 0.0 
509 558 54.2 472 45.8 0 0.0 
513 387 37.6 643 62.4 0 0.0 
514 681 66.1 349 33.9 0 0.0 
516 142 13.8 886 86.0 2 0.2 
517 199 19.3 829 80.5 2 0.2 
520 85 8.3 944 91.7 1 0.1 
521 506 49.1 523 50.8 1 0.1 
530 45 4.4 984 95.5 1 0.1 
535 617 59.9 411 39.9 2 0.2 
536 294 28.5 735 71.4 1 0.1 
539 228 22.1 800 77.7 2 0.2 
540 99 9.6 930 90.3 1 0.1 
542 533 51.7 496 48.2 1 0.1 
546 140 13.6 888 86.2 2 0.2 
547 514 49.9 516 50.1 0 0.0 
548 133 12.9 896 87.0 1 0.1 
549 345 33.5 685 66.5 0 0.0 




Table 1. Continued.       
Item number  True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
552 632 61.4 396 38.4 2 0.2 
556 642 62.3 388 37.7 0 0.0 
564 357 34.7 671 65.1 2 0.2 
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Factor loadings for 6-factor EFA model (53 items)   
    
Item number Item content F1 F2 F3 F4 F5 F6 
28 Frequent stomach aches (T) .861* -.084 -.084* .042 .044 -.020 
53 Burning/tingling sensation all over body (T) .519* .206* -.072 -.054 .020 .004 
57 Never feel pain in back of neck (F) .523* .030 -.033 -.049 .013 .027 
97 Fullness in head/nose most of the time (T) .455* .205* .082 .049 .016 -.024 
101 Feeling of a tight band around head (T) .593* .071 .076 .206* .005 .064 
111 Frequent stomach trouble (T) .959* -.105 .008 .068 .000 -.100 
149 Tenderness atop head (T) .496* .110 .035 -.042 -.051 .073 
181 No hay fever/asthma (F) .403* .017 -.074 -.010 -.085 .004 
247 Numbness on skin (T) .521* .101 -.012 .007 -.125* .035 
536 Upset leads to headache (T) .480* .168* -.013 -.074 .123* .070 
81 Most people would lie to do better than others (T) -.055 .743* -.017 -.078 .081 .044 
99 Someone is out to get me (T) .055 .673* .142* .189* -.048 .070 
110 Most people will act unfairly to get ahead (T)  -.011 .838* -.010 -.087 .032 -.066 
138 People are plotting against me (T) .074 .696* .142 .087 -.016 -.018 
259 People are talking about me (T) -.023 .473* -.008 .148* .126* .228* 
284 People lie to get out of things (T) -.020 .667* .004 -.054 .013 -.070 
286 People dislike helping others (T)  .031 .652* .001 .016 -.021 -.025 
333 People insult me (T) .087 .418* -.046 .060 -.037 .258* 
346 Just as good as experts (T)  .020 .420* -.032 -.073 -.172* .144* 
484 People are unkind (T)  .122 .402* -.133 .123 .077 .089 
86 Like loud, fun parties (T) -.050 .069* .866* .076 .081 .073 
189 Enjoy flirting (T) -.047 .076 .501* .002 -.069 .105* 
231 Like being friends with pranksters (T)  -.010 .086 .492* .089 -.099* -.077 
337 More likely to be a wallflower at a party (T)  -.039 .049 -.705* .093* .128* .074 
349 Happiest alone (T) -.052 .241* -.411* .113 .061 -.050 
353 Enjoy just being with other people (T) .031 -.060 .834* -.068 .018 -.016 
359 Find crowds exciting (T)  -.004 .027 .854* -.052 .072 -.030 
363 Worries melt in a lively crowd (T) -.076 .111* .539* -.125* -.009 .047 




Table 3. Continued. 
Item number Item content F1 F2 F3 F4 F5 F6 
370 Enjoy parties (T) -.020 -.040 .966* .035 .021 -.001 
61 Feel important (T) -.016 .095* .174* -.518* -.060 .035 
75 Life is usually worthwhile (F) -.062 .004 -.052 .765* .015 .019 
92 Uncaring about what happens to me (T) -.018 .194* .016 .668* -.046 -.048 
303 Frequent suicidal thoughts (T)  .028 -.024 .015 .880* .000 .084 
454 Hopeless future (T)  .044 -.023 -.023 .809* .133* .029 
516 Empty/meaningless life (T)  -.025 .091 -.061 .846* .071 -.082 
520 Recent suicidal thoughts (T)  .025 -.032 -.015 .730* -.114 .109 
539 Loss of desire to make things better (T) .052 .137* .036 .545* .119* .049 
546 Thoughts of death and afterlife (T) .169* .049 -.050 .601* -.062 -.015 
70 Easily defeated in arguments (T) .049 .015 -.029 .027 .666* -.061 
146 It is easy to make me cry (T) .277* -.139* .024 -.002 .426* .222* 
289 Easily embarrassed (T) .050 .061 -.222* -.125* .621* .141* 
421 Vulnerable to criticism (T) -.023 .210* -.088 .038 .561* .003 
457 Changeable opinions (T) -.155* -.022 .127* .021 .718* .014 
503 Passive/follower (T) -.075 .009 -.107* .049 .683* -.104* 
509 Nervous about important decisions (T) .117* -.031 -.021 .051 .673* .015 
514 Difficult time saying no (T) .146* .063 .067 -.030 .486* .006 
213 Anger easily but calm down quickly (T) -.037 .074 .150* -.056 .087 .605* 
372 Difficult to anger (F) -.026 .025 -.072 .036 -.017 .850* 
382 Frequent serious arguments with close others (T) .005 .252* -.047 .046 -.018 .437* 
389 Hotheaded (T) .031 -.010 -.044 -.030 -.141* .855* 
444 High-strung (T) .089 -.084 .048 .033 .114* .447* 
542 Intense anger (T) .087 .154* .056 .039 .038 .515* 
564 Never lose self control (F)  -.043 -.050 .035 .222* .054 .528* 
Note. Item content was altered to protect MMPI-2 copyright. 
*p < .05. 





Factor correlations for 6-factor EFA model 
 F1 F2 F3 F4 F5 
F1: Somatizing - - - - - 
F2: Ant. suspiciousness .214* - - - - 
F3: Extraversion -.136* -.050 - - - 
F4: Depression .290* .207* -.341* - - 
F5: Passivity .124* .192* -.225* .316* - 
F6: Anger .273* .319* -.008 .222* .200* 









































































Model fit indices for EFA and EBFA 
Model χ² (df) 
RMSEA 
(90% CI) CFI SRMR 
5-factor EFA (155 items) 14261.94 (11170) .02 .92 .06 
6-factor EFA (53 items) 1825.11 (1122) .03 .96 .05 
7-factor EFA (155 items) 12893.20 (10871) .01 .95 .06 
8-factor EFA (155 items) 12375.01 (10723) .01 .96 .05 
9-factor EFA (155 items) 11938.56 (10576) .01 .96 .05 
10-factor EFA (155 items) 11600.02 (10430) .01 .97 .05 
11-factor EFA (155 items) 11321.26 (10285) .01 .97 .05 
12-factor EFA (155 items) 11047.41 (10141) .01 .98 .05 
13-factor EFA (155 items) 10797.46 (9998) .01 .98 .05 
     
3-factor EBFA (53 items) 4050.75 (1272) .05 .83 .09 
4-factor EBFA (53 items) 3125.62 (1221) .04 .89 .08 
5-factor EBFA (53 items) 2475.32 (1171) .03 .92 .06 
6-factor EBFA (53 items) 1825.11 (1122) .03 .96 .05 
7-factor EBFA (53 items) 1491.21 (1074) .02 .98 .05 
8-factor EBFA (53 items) 1327.30 (1027) .02 .98 .04 
9-factor EBFA (53 items) 1215.24 (981) .02 .99 .04 
10-factor EBFA (53 items) 1124.83 (936) .01 .99 .04 
11-factor EBFA (53 items) 1040.18 (892) .01 .99 .03 
12-factor EBFA (53 items) 953.02 (849) .01 .99 .03 
13-factor EBFA (53 items) 877.92 (807) .01 1.00 .03 
Note. χ² = chi-square goodness of fit, df = degrees of freedom, RMSEA = root mean square error 
of approximation, CFI = comparative fit index, SRMR = standardized root mean square residual. 





Factor loadings for 6-factor EBFA model (53 items)   
    
Item number Item content G S1 S2 S3 S4 S5 
28 Frequent stomach aches (T) .253* .813* -.081* .052 .047 -.003 
53 Burning/tingling sensation all over body (T) .371* .475* -.059 -.089 .003 -.021 
57 Never feel pain in back of neck (F) .209* .490* -.029 -.052 .010 .023 
97 Fullness in head/nose most of the time (T) .353* .415* .093 .004 -.003 -.048 
101 Feeling of a tight band around head (T) .380* .551* .083 .172* -.006 .046 
111 Frequent stomach trouble (T) .209* .908* .008 .079 .007 -.071 
149 Tenderness atop head (T) .268* .460* .042 -.060 -.059 .053 
181 No hay fever/asthma (F) .136* .379* -.070 -.012 -.082 .004 
247 Numbness on skin (T) .255* .486* -.006 -.013 -.128* .020 
536 Upset leads to headache (T) .369* .439* -.002 -.101 .102* .042 
86 Like loud, fun parties (T) -.002 -.051 .856* .052 .063 .053 
189 Enjoy flirting (T) -.001 -.047 .497* -.014 -.076 .083 
231 Like being friends with pranksters (T)  -.035 -.011 .486* .063 -.103* -.080 
337 More likely to be a wallflower at a party (T)  .272* -.046 -.689* .078 .119* .057 
349 Happiest alone (T) .328* -.067 -.393* .059 .041 -.079 
353 Enjoy just being with other people (T) -.219* .036 .817* -.054 .018 -.005 
359 Find crowds exciting (T)  -.132* -.003 .841* -.056 .062 -.030 
363 Worries melt in a lively crowd (T) -.046 -.076 .534* -.137* -.020 .028 
367 Avoid crowds (T)  .384* -.037 -.757* -.004 .048 -.011 
370 Enjoy parties (T) -.185* -.013 .948* .035 .016 .004 
61 Feel important (T) -.174* -.016 .170* -.488* -.059 .026 
75 Life is usually worthwhile (F) .338* -.064 -.044 .694* .004 .004 
92 Uncaring about what happens to me (T) .429* -.031 .030 .570* -.067 -.078 
303 Frequent suicidal thoughts (T)  .407* .021 .022 .804* -.011 .064 
516 Empty/meaningless life (T)  .442* -.035 -.048 .750* .050 -.098 
520 Recent suicidal thoughts (T)  .311* .022 -.009 .669* -.117 .090 
539 Loss of desire to make things better (T) .443* .034 .048 .468* .093 .017 




Table 7. Continued. 
Item number Item content G S1 S2 S3 S4 S5 
546 Thoughts of death and afterlife (T) .348* .154* -.042 .537* -.070 -.028 
70 Easily defeated in arguments (T) .243* .032 -.024 .016 .630* -.059 
146 It is easy to make me cry (T) .205* .258* .024 .020 .409* .214* 
289 Easily embarrassed (T) .334* .030 -.211* -.129* .583* .116* 
421 Vulnerable to criticism (T) .414* -.046 -.074 -.009 .514* -.028 
457 Changeable opinions (T) .162* -.159* .128* .017 .680* .011 
503 Passive/follower (T) .204* -.085 -.101* .038 .647* -.097* 
509 Nervous about important decisions (T) .269* .098* -.016 .046 .638* .014 
514 Difficult time saying no (T) .252* .124* .072 -.044 .454* -.004 
213 Anger easily but calm down quickly (T) .324* -.046 .156* -.066 .065 .524* 
372 Difficult to anger (F) .439* -.034 -.062 .029 -.033 .746* 
382 Frequent serious arguments with close others (T) .470* -.015 -.031 -.005 -.045 .352* 
389 Hotheaded (T) .352* .025 -.036 -.023 -.148* .758* 
444 High-strung (T) .207* .083 .049 .045 .106* .405* 
542 Intense anger (T) .441* .067 .068 .006 .013 .434* 
564 Never lose self control (F)  .297* -.045 .040 .211* .043 .469* 
81 Most people would lie to do better than others (T) .707* -.098 .015 -.211* .019 -.060 
99 Someone is out to get me (T) .736* .010 .171* .044 -.103 -.030 
110 Most people will act unfairly to get ahead (T)  .740* -.061 .025 -.237* -.034 -.169* 
138 People are plotting against me (T) .690* .027 .170* -.053 -.072 -.110 
259 People are talking about me (T) .659* -.056 .017 .044 .076 .135* 
284 People lie to get out of things (T) .577* -.059 .031 -.174* -.038 -.150* 
286 People dislike helping others (T)  .621* -.010 .029 -.108 -.071 -.110 
333 People insult me (T) .572* .054 -.024 -.023 -.074 .171* 
346 Just as good as experts (T)  .391* -.005 -.014 -.143* -.197* .073 
484 People are unkind (T)  .570* .087 -.111 .036 .039 .023 
Note. Item content was altered to protect MMPI-2 copyright. 
*p < .05. 




Factor correlations for 6-factor EBFA model 
 G S1 S2 S3 S4 
General factor - - - - - 
S1: Somatizing .000 - - - - 
S2: Extraversion .000 -.094* - - - 
S3: Depression .000 .181* -.307* - - 
S4: Passivity .000 .037 -.185* .230* - 





Study 2 PD Spectra Scale Items Frequencies (N = 539) 
Item number True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
28 153 28.4 386 71.6 0 0.0 
53 234 43.4 305 56.6 0 0.0 
57 231 42.9 308 57.1 0 0.0 
61 321 59.6 216 40.1 2 0.4 
70 180 33.4 357 66.2 2 0.4 
75 187 34.7 347 64.4 5 0.9 
81 348 64.6 189 35.1 2 0.4 
86 234 43.4 305 56.6 0 0.0 
92 183 34.0 356 66.0 0 0.0 
97 142 26.3 391 72.5 6 1.1 
99 169 31.4 370 68.6 0 0.0 
101 142 26.3 395 73.3 2 0.4 
110 359 66.6 179 33.2 1 0.2 
111 119 22.1 420 77.9 0 0.0 
138 136 25.2 403 74.8 0 0.0 
146 200 37.1 338 62.7 1 0.2 
149 122 22.6 417 77.4 0 0.0 
181 141 26.2 398 73.8 0 0.0 
189 274 50.8 265 49.2 0 0.0 
213 213 39.5 326 60.5 0 0.0 
231 161 29.9 377 69.9 1 0.2 
247 116 21.5 423 78.5 0 0.0 
259 279 51.8 260 48.2 0 0.0 
284 299 55.5 240 44.5 0 0.0 
286 266 49.4 269 49.9 4 0.7 
289 266 49.4 273 50.6 0 0.0 
303 134 24.9 404 75.0 1 0.2 
333 166 30.8 372 69.0 1 0.2 
337 324 60.1 215 39.9 0 0.0 
346 339 62.9 197 36.5 3 0.6 
349 133 24.7 405 75.1 1 0.2 
353 290 53.8 249 46.2 0 0.0 
359 274 50.8 263 48.8 2 0.4 
363 253 46.9 285 52.9 1 0.2 
367 261 48.4 278 51.6 0 0.0 
370 311 57.7 226 41.9 2 0.4 
372 221 41.0 317 58.8 1 0.2 
382 185 34.3 352 65.3 2 0.4 
389 152 28.2 387 71.8 0 0.0 
421 184 34.1 353 65.5 2 0.4 
444 234 43.4 304 56.4 1 0.2 
454 184 34.1 355 65.9 0 0.0 




Table 9. Continued. 
Item number True (N) True (%) False (N) False (%) Missing (N) Missing (%) 
484 116 21.5 422 78.3 1 0.2 
503 186 34.5 353 65.5 0 0.0 
509 249 46.2 290 53.8 0 0.0 
514 342 63.5 197 36.5 0 0.0 
516 169 31.4 370 68.6 0 0.0 
520 167 31.0 370 68.6 2 0.4 
536 184 34.1 355 65.9 0 0.0 
539 217 40.3 321 59.6 1 0.2 
542 289 53.6 249 46.2 1 0.2 
546 174 32.3 364 67.5 1 0.2 





Standardized factor loadings for 6-factor CFA model (53 items)   
    
Item number Item content F1 F2 F3 F4 F5 F6 
28 Frequent stomach aches (T) .803*      
53 Burning/tingling sensation all over body (T) .800*      
57 Never feel pain in back of neck (F) .601*      
97 Fullness in head/nose most of the time (T) .730*      
101 Feeling of a tight band around head (T) .830*      
111 Frequent stomach trouble (T) .779*      
149 Tenderness atop head (T) .608*      
181 No hay fever/asthma (F) .205*      
247 Numbness on skin (T) .616*      
536 Upset leads to headache (T) .690*      
81 Most people would lie to do better than others (T)  .665*     
99 Someone is out to get me (T)  .859*     
110 Most people will act unfairly to get ahead (T)   .677*     
138 People are plotting against me (T)  .890*     
259 People are talking about me (T)  .836*     
284 People lie to get out of things (T)  .444*     
286 People dislike helping others (T)   .683*     
333 People insult me (T)  .726*     
346 Just as good as experts (T)   .317*     
484 People are unkind (T)   .886*     
86 Like loud, fun parties (T)  .448* .916*    
189 Enjoy flirting (T)   .288*    
231 Like being friends with pranksters (T)    .194*    
337 More likely to be a wallflower at a party (T)    -.804*    
349 Happiest alone (T)   -.712*    
353 Enjoy just being with other people (T)   .839*    
359 Find crowds exciting (T)    .726*    
363 Worries melt in a lively crowd (T)   .565*    




Table 10. Continued. 
Item number Item content F1 F2 F3 F4 F5 F6 
370 Enjoy parties (T)   .890*    
61 Feel important (T)    -.696*   
75 Life is usually worthwhile (F)    .819*   
92 Uncaring about what happens to me (T)    .793*   
303 Frequent suicidal thoughts (T)     .893*   
454 Hopeless future (T)     .909*   
516 Empty/meaningless life (T)     .889*   
520 Recent suicidal thoughts (T)     .743*   
539 Loss of desire to make things better (T)    .865*   
546 Thoughts of death and afterlife (T)    .831*   
70 Easily defeated in arguments (T)     .731*  
146 It is easy to make me cry (T)     .635*  
289 Easily embarrassed (T)     .703*  
421 Vulnerable to criticism (T)     .738*  
457 Changeable opinions (T)     .701*  
503 Passive/follower (T)     .759*  
509 Nervous about important decisions (T)     .827*  
514 Difficult time saying no (T)     .506*  
213 Anger easily but calm down quickly (T)      .373* 
372 Difficult to anger (F)      .723* 
382 Frequent serious arguments with close others (T)      .704* 
389 Hotheaded (T)      .564* 
444 High-strung (T)      .384* 
542 Intense anger (T)      .746* 
564 Never lose self control (F)       .742* 
Note. Item content was altered to protect MMPI-2 copyright. 






Factor correlations for 6-factor CFA model 
 F1 F2 F3 F4 F5 
F1: Somatizing - - - - - 
F2: Ant. suspiciousness .609* - - - - 
F3: Extraversion -.414* -.447* - - - 
F4: Depression .594* .607* -.556* - - 
F5: Passivity .628* .606* -.578* .641* - 






Table 12  
Standardized factor loadings for 6-factor CBFA model (53 items)  
    
Item number Item content G S1 S2 S3 S4 S5 
28 Frequent stomach aches (T) .528* .686*     
53 Burning/tingling sensation all over body (T) .634* .374*     
57 Never feel pain in back of neck (F) .443* .427*     
97 Fullness in head/nose most of the time (T) .595* .274*     
101 Feeling of a tight band around head (T) .659* .383*     
111 Frequent stomach trouble (T) .472* .823*     
149 Tenderness atop head (T) .460* .380*     
181 No hay fever/asthma (F) .115 .291*     
247 Numbness on skin (T) .471* .361*     
536 Upset leads to headache (T) .545* .340*     
86 Like loud, fun parties (T) -.132*  .813*    
189 Enjoy flirting (T) -.059  .499*    
231 Like being friends with pranksters (T)  -.034  .361*    
337 More likely to be a wallflower at a party (T)  .532*  -.532*    
349 Happiest alone (T) .541*  -.282*    
353 Enjoy just being with other people (T) -.510*  .658*    
359 Find crowds exciting (T)  -.364*  .719*    
363 Worries melt in a lively crowd (T) -.340*  .451*    
367 Avoid crowds (T)  .597*  -.594*    
370 Enjoy parties (T) -.480*  .822*    
61 Feel important (T) -.520*   -.493*   
75 Life is usually worthwhile (F) .611*   .578*   
92 Uncaring about what happens to me (T) .633*   .449*   
303 Frequent suicidal thoughts (T)  .671*   .612*   
454 Hopeless future (T)  .723*   .531*   
516 Empty/meaningless life (T)  .697*   .546*   
520 Recent suicidal thoughts (T)  .535*   .585*   





Table 12. Continued. 
Item number Item content G S1 S2 S3 S4 S5 
546 Thoughts of death and afterlife (T) .653*   .510*   
70 Easily defeated in arguments (T) .552*    .554*  
146 It is easy to make me cry (T) .519*    .294*  
289 Easily embarrassed (T) .546*    .452*  
421 Vulnerable to criticism (T) .582*    .455*  
457 Changeable opinions (T) .525*    .603*  
503 Passive/follower (T) .617*    .363*  
509 Nervous about important decisions (T) .676*    .360*  
514 Difficult time saying no (T) .380*    .448*  
213 Anger easily but calm down quickly (T) .192*     .546* 
372 Difficult to anger (F) .480*     .596* 
382 Frequent serious arguments with close others (T) .494*     .363* 
389 Hotheaded (T) .327*     .699* 
444 High-strung (T) .214*     .520* 
542 Intense anger (T) .509*     .466* 
564 Never lose self control (F)  .542*     .252* 
81 Most people would lie to do better than others (T) .581*      
99 Someone is out to get me (T) .793*      
110 Most people will act unfairly to get ahead (T)  .591*      
138 People are plotting against me (T) .825*      
259 People are talking about me (T) .754*      
284 People lie to get out of things (T) .380*      
286 People dislike helping others (T)  .609*      
333 People insult me (T) .652*      
346 Just as good as experts (T)  .263*      
484 People are unkind (T)  .795*      
Note. Item content was altered to protect MMPI-2 copyright. 






Model fit indices for CFA and CBFA (53 items) 
Model χ² (df) RMSEA (90% CI) CFI 
6-factor CFA 2308.19 (1361) .04 .94 
   CFA with MCMI-II correlations 3493.90 (1985) .04 .91 
   CFA with MCMI-II regressions 3493.90 (1985) .04 .91 
6-factor CBFA 2343.43 (1333) .04 .93 
   CBFA with MCMI-II correlations 3335.85 (1957) .04 .91 
   CBFA with MCMI-II regressions 3335.85 (1957) .04 .91 
Note. χ² = chi-square goodness of fit, df = degrees of freedom, RMSEA = root mean square error 






MCMI-II Clinical Scale Score Descriptives (N = 539) 
Scale M SD 
Schizoid 70.41 27.38 
Avoidant 67.93 32.70 
Dependent 63.74 29.75 
Narcissistic 56.55 29.52 
Antisocial 59.14 28.45 
Histrionic 50.85 26.67 
Aggressive/sadistic 59.39 29.08 
Compulsive 62.35 21.92 
Passive-aggressive 58.58 36.84 
Self-defeating 63.39 28.26 
Schizotypal 65.25 25.52 
Borderline 58.15 26.22 
Paranoid 58.96 21.30 





MCMI-II Clinical Scales Correlations (N = 539) 
 SZD AVD DEP NAR ANT HIS AGG OBC PAG SLF SZT BOR PAR 
SZD --             
AVD .761* --            
DEP .276* .289* --           
NAR -.125* .000 -.222* --          
ANT .181* .380* -.234* .716* --         
HIS -.391* -.189* .047 .698* .467* --        
AGG .130* .262* -.318* .769* .799* .440* --       
OBC .199* -.001 .335* .105* -.141* .004 .067 --      
PAG .407* .657* -.043 .441* .767* .228* .678* -.228* --     
SLF .582* .835* .413* .098* .436* .059 .293* -.048 .707* --    
SZT .735* .806* .302* .170* .477* -.074 .367* .077 .668* .751* --   
BOR .430* .690* .108* .399* .699* .271* .584* -.124* .852* .799* .689* --  
PAR .299* .426* .062 .706* .694* .409* .707* .289* .620* .472* .573* .633* -- 
Note. SZD = Schizoid, AVD = Avoidant, DEP = Dependent, NAR = Narcissistic, ANT = Antisocial, HIS = Histrionic, AGG = 
Aggressive/Sadistic, OBC = Compulsive, PAG = Passive-aggressive, SLF = Self-defeating, SZT = Schizotypal, BOR = Borderline, 
PAR = Paranoid. 





Table 16  
CFA factor correlations with MCMI-II Clinical Scales 
 SZD AVD DEP HIS NAR ANT AGG OBC PAG SLF SZT BOR PAR 
F1: Somatizing .287* .402* .027 -.165* -.046 .171* .121* -.179* .412* .374* .383* .349* .221* 
F2: Ant. susp. .325* .461* .019 -.141* .106* .342* .225* -.267* .514* .426* .499* .425* .342* 
F3: Extraversion -.650* -.590* -.026 .578* .290* -.023 .018 .019 -.285* -.361* -.529* -.221* -.099* 
F4: Depression .437* .534* -.014 -.325* -.190* .196* .080 -.326* .453* .486* .460* .450* .079 
F5: Passivity .435* .618* .411* -.276* -.291* .060 -.114* -.201* .430* .611* .547* .411* .102 
F6: Anger .116* .385* -.255* .121* .309* .558* .516* -.369* .713* .444* .378* .610* .416* 
Note. SZD = Schizoid, AVD = Avoidant, DEP = Dependent, HIS = Histrionic, NAR = Narcissistic, ANT = Antisocial, AGG = 
Aggressive/Sadistic, OBC = Compulsive, PAG = Passive-aggressive, SLF = Self-defeating, SZT = Schizotypal, BOR = Borderline, 
PAR = Paranoid. 





MCMI-II Clinical Scales regressed on CFA factors 
 β SE B SE 95% CI R2 
     Lower Upper  
Schizoid       .449 
   F1: Somatizing -.016 .050 -.016 .050 -.114 .083  
   F2: Ant. susp. .063 .047 .063 .047 -.028 .155  
   F3: Extraversion -.547 .035 -.547* .043 -.630 -.463  
   F4: Depression .146 .045 .146* .045 .057 .235  
   F5: Passivity .077 .054 .077 .054 -.028 .183  
   F6: Anger -.171 .064 -.170* .064 -.296 -.045  
Avoidant       .484 
   F1: Somatizing -.103 .054 -.103 .054 -.208 .003  
   F2: Ant. susp. .033 .043 .032 .043 -.052 .117  
   F3: Extraversion -.325 .044 -.325* .048 -.420 -.230  
   F4: Depression .105 .046 .105* .046 .015 .195  
   F5: Passivity .352 .046 .352* .051 .252 .452  
   F6: Anger .117 .057 .117* .057 .005 .230  
Dependent       .514 
   F1: Somatizing -.081 .077 -.081 .077 -.231 .070  
   F2: Ant. susp. .044 .070 .044 .070 -.137 .182  
   F3: Extraversion .280 .071 .280* .072 .095 .421  
   F4: Depression -.163 .076 -.163* .077 -.361 -.012  
   F5: Passivity .945 .084 .944* .100 .685 1.141  
   F6: Anger -.519 .073 -.518* .079 -.722 -.363  
Histrionic       .442 
   F1: Somatizing -.054 .063 -.054 .063 -.177 .069  
   F2: Ant. susp. .009 .061 .009 .061 -.111 .128  
   F3: Extraversion .557 .056 .557* .064 .432 .682  
   F4: Depression -.221 .065 -.221* .066 -.350 -.092  
   F5: Passivity .031 .073 .031 .073 -.113 .174  
   F6: Anger .396 .066 .396* .070 .259 .533  
Narcissistic       .419 
   F1: Somatizing -.031 .076 -.031 .076 -.179 .117  
   F2: Ant. susp. .276 .065 .276* .067 .145 .407  
   F3: Extraversion .135 .059 .135* .059 .018 .251  
   F4: Depression -.275 .068 -.275* .070 -.412 -.138  
   F5: Passivity -.439 .077 -.439* .080 -.596 -.282  
   F6: Anger .546 .068 .545* .073 .402 .689  
Antisocial       .388 
   F1: Somatizing -.149 .077 -.149 .077 -.299 .002  
   F2: Ant. susp. .195 .060 .195* .060 .077 .313  
   F3: Extraversion .019 .062 .019 .062 -.102 .141  
   F4: Depression -.014 .072 -.014 .072 -.154 .127  
   F5: Passivity -.250 .080 -.250* .080 -.407 -.094  




Table 17. Continued 
 β SE B SE 95% CI R2 
     Lower Upper  
Aggressive/Sadistic       .441 
   F1: Somatizing -.037 .078 -.037 .078 -.189 .115  
   F2: Ant. susp. .106 .062 .106 .062 -.107 .228  
   F3: Extraversion -.098 .063 -.098 .063 -.221 .025  
   F4: Depression -.092 .072 -.092 .072 -.233 .049  
   F5: Passivity -.492 .080 -.492* .081 -.651 -.333  
   F6: Anger .727 .066 .726* .072 .585 .867  
Compulsive       .202 
   F1: Somatizing .143 .072 .143* .072 .002 .284  
   F2: Ant. susp. -.061 .064 -.061 .064 -.186 .064  
   F3: Extraversion -.228 .060 -.228* .061 -.347 -.109  
   F4: Depression -.319 .068 -.319* .070 -.456 -.181  
   F5: Passivity -.052 .075 -.052 .075 -.199 .095  
   F6: Anger -.276 .075 -.276* .076 -.425 -.126  
Passive-aggressive       .530 
   F1: Somatizing -.108 .066 -.108 .066 -.239 .022  
   F2: Ant. susp. .079 .050 .079 .050 -.018 .177  
   F3: Extraversion -.056 .054 -.056 .055 -.163 .051  
   F4: Depression .026 .059 .026 .059 -.090 .142  
   F5: Passivity .095 .062 .095 .062 -.026 .216  
   F6: Anger .653 .058 .652* .074 .508 .797  
Self-defeating       .421 
   F1: Somatizing -.154 .056 -.153* .056 -.262 -.044  
   F2: Ant. susp. -.011 .046 -.011 .046 -.101 .078  
   F3: Extraversion .006 .055 .006 .055 -.102 .113  
   F4: Depression .127 .049 .127* .050 .029 .224  
   F5: Passivity .532 .050 .531* .056 .422 .641  
   F6: Anger .223 .057 .223* .058 .109 .337  
Schizotypal       .406 
   F1: Somatizing -.082 .051 -.081 .051 -.182 .019  
   F2: Ant. susp. .196 .037 .196* .038 .122 .270  
   F3: Extraversion -.298 .042 -.298* .044 -.383 -.212  
   F4: Depression .004 .041 .004 .041 -.076 .084  
   F5: Passivity .257 .047 .257* .047 .164 .350  
   F6: Anger .103 .058 .103 .058 -.009 .216  
Borderline       .411 
   F1: Somatizing -.143 .064 -.143* .064 -.268 -.017  
   F2: Ant. susp. .003 .049 .003 .049 -.093 .098  
   F3: Extraversion .050 .057 .050 .057 -.062 .163  
   F4: Depression .162 .053 .161* .053 .058 .265  
   F5: Passivity .173 .064 .173* .065 .046 .300  
   F6: Anger .535 .053 .535* .059 .418 .651  




Table 17. Continued 
 β SE B SE 95% CI R2 
     Lower Upper  
   F1: Somatizing .041 .070 .041 .070 -.095 .178  
   F2: Ant. susp. .285 .053 .284* .053 .180 .389  
   F3: Extraversion -.108 .062 -108 .062 -.230 .015  
   F4: Depression -.302 .067 -.302* .067 -.434 -.170  
   F5: Passivity -.164 .080 -.164* .080 -.321 -.007  
   F6: Anger .429 .061 .428* .063 .305 .551  
Note. β = standardized beta weight, SE = standard error, B = unstandardized beta weight, CI = 
confidence interval, R2 = coefficient of determination. 
R2 value represents the total amount of variance explained in the MCMI-II scale by the 6 factors. 
Significant unstandardized beta weights have been bolded to improve readability. 






CBFA factor correlations with MCMI-II Clinical Scales 
 SZD AVD DEP HIS NAR ANT AGG OBC PAG SLF SZT BOR PAR 
General factor .394* .547* -.012 -.154* .110* .409* .282* -.313* .602* .504* .577* .512* .383* 
S1: Somatizing -.021 -.017 .057 -.081 -.203* -.215* -.159* .084 -.055 -.006 -.061 -.061 -.106 
S2: 
Extraversion 
-.512* -.304* -.062 .620* .463* .319* .274* -.226* .124* -.049 .140* .140* .188* 
S3: Depression .205* .168* -.009 -.339* -.449* -.202* -.230* -.138* -.026 .145* .071 .071 -.364* 
S4: Passivity .203* .309* .686* -.250* -.594* -.422* -.542* .077 -.066 .348* .014 .014 -.312* 
S5: Anger -.193* .028 -.319* .319* .347* .392* .448* -.190* .409* .141* .357* .357* .234* 
Note. SZD = Schizoid, AVD = Avoidant, DEP = Dependent, HIS = Histrionic, NAR = Narcissistic, ANT = Antisocial, AGG = 
Aggressive/Sadistic, OBC = Compulsive, PAG = Passive-aggressive, SLF = Self-defeating, SZT = Schizotypal, BOR = Borderline, 
PAR = Paranoid. 





MCMI-II Clinical Scales regressed on CBFA factors 
 β SE B SE 95% CI R2 
     Lower Upper  
Schizoid       .538 
   General factor .394 .038 .392* .043 .309 .478  
   S1: Somatizing -.021 .045 -.021 .045 -.109 .068  
   S2: Extraversion -.512 .031 -.511* .037 -.584 -.438  
   S3: Depression .205 .037 .205* .038 .130 .279  
   S4: Passivity .203 .044 .203* .045 .114 .291  
   S5: Anger -.193 .047 -.193* .048 -.286 -.100  
Avoidant       .516 
   General factor .547 .041 .546* .055 .438 .655  
   S1: Somatizing -.017 .046 -.017 .046 -.106 .072  
   S2: Extraversion -.304 .036 -.303* .040 -.382 -.225  
   S3: Depression .168 .037 .168* .038 .093 .243  
   S4: Passivity .309 .037 .308* .041 .228 .389  
   S5: Anger .028 .044 .028 .044 -.058 .113  
Dependent       .580 
   General factor -.012 .047 -.012 .047 -.103 .080  
   S1: Somatizing .057 .057 .057 .057 -.054 .168  
   S2: Extraversion -.062 .054 -.062 .054 -.169 .045  
   S3: Depression -.009 .065 -.009 .064 -.136 .117  
   S4: Passivity .686 .052 .685* .068 .552 .818  
   S5: Anger -.319 .052 -.319* .056 -.429 -.208  
Histrionic       .694 
   General factor -.154 .045 -.154* .047 -.245 -.062  
   S1: Somatizing -.081 .055 -.081 .055 -.189 .028  
   S2: Extraversion .620 .041 .619* .056 .510 .729  
   S3: Depression -.339 .059 -.338* .063 -.463 -.214  
   S4: Passivity -.250 .062 -.250* .064 -.375 -.124  
   S5: Anger .392 .047 .319* .051 .218 .420  
Narcissistic       .942 
   General factor .110 .048 .110* .048 .015 .205  
   S1: Somatizing -.203 .060 -.203* .061 -.323 -.083  
   S2: Extraversion .463 .052 .462* .058 .348 .576  
   S3: Depression -.449 .059 -.448* .066 -.577 -.320  
   S4: Passivity -.594 .063 -.594* .073 -.736 -.451  
   S5: Anger .347 .048 .347* .052 .244 .450  
Antisocial       .687 
   General factor .409 .045 .408* .049 .312 .505  
   S1: Somatizing -.215 .056 -.215* .057 -.328 -.103  
   S2: Extraversion .319 .052 .318* .054 .213 .424  
   S3: Depression -.202 .061 -.201* .061 -.322 -.081  
   S4: Passivity -.422 .062 -.421* .065 -.548 -.294  




Table 19. Continued. 
 β SE B SE 95% CI R2 
     Lower Upper  
Aggressive/Sadistic       .724 
   General factor .282 .045 .281* .048 .188 .375  
   S1: Somatizing -.150 .057 -.150* .058 -.263 -.037  
   S2: Extraversion .274 .055 .274* .057 .163 .385  
   S3: Depression -.230 .060 -.230* .061 -.349 -.110  
   S4: Passivity -.542 .059 -.542* .064 -.668 -.415  
   S5: Anger .448 .044 .447* .049 .351 .543  
Compulsive       .217 
   General factor -.313 .044 -.313* .047 -.404 -.221  
   S1: Somatizing .084 .056 .084 .056 -.026 .194  
   S2: Extraversion -.226 .049 -.225* .050 -.323 -.128  
   S3: Depression -.138 .054 -.137* .055 -.244 -.031  
   S4: Passivity .077 .057 .007 .057 -.034 .188  
   S5: Anger -.190 .051 -.190* .051 -.290 -.089  
Passive-aggressive       .554 
   General factor .602 .040 .602* .059 .486 .718  
   S1: Somatizing -.055 .048 -.055 .048 -.150 .039  
   S2: Extraversion .124 .044 .123* .045 .036 .211  
   S3: Depression -.026 .047 -.026 .047 -.118 .067  
   S4: Passivity -.066 .051 -.066 .051 -.165 .034  
   S5: Anger .409 .039 .409* .046 .318 .499  
Self-defeating       .418 
   General factor .504 .040 .503* .049 .408 .599  
   S1: Somatizing -.006 .044 -.006 .044 -.093 .080  
   S2: Extraversion -.049 .042 -.049 .042 -.132 .033  
   S3: Depression .145 .038 .145* .039 .068 .222  
   S4: Passivity .348 .038 .347* .041 .266 .428  
   S5: Anger .141 .042 .141* .043 .057 .225  
Schizotypal       .407 
   General factor .577 .033 .576* .041 .497 .656  
   S1: Somatizing -.090 .041 -.090* .042 -.171 -.008  
   S2: Extraversion -.202 .036 -.202* .036 -.273 -.131  
   S3: Depression .012 .033 .011 .033 -.053 .076  
   S4: Passivity .156 .034 .156* .034 .089 .224  
   S5: Anger .005 .042 .005 .042 -.078 .088  
Borderline       .419 
   General factor .512 .041 .512* .048 .418 .606  
   S1: Somatizing -.061 .048 -.061 .048 -.154 .032  
   S2: Extraversion .140 .044 .140* .044 .053 .226  
   S3: Depression .071 .043 .071 .043 -.014 .156  
   S4: Passivity .014 .048 .014 .048 -.081 .109  
   S5: Anger .358 .037 .357* .040 .279 .436  




Table 19. Continued. 
 β SE B SE 95% CI R2 
     Lower Upper  
   General factor .383 .045 .383* .047 .292 .474  
   S1: Somatizing -.106 .056 -.106 .056 -.215 .003  
   S2: Extraversion .188 .052 .187* .052 .085 .290  
   S3: Depression -.364 .054 -.364* .055 -.472 -.256  
   S4: Passivity -.312 .061 -.312* .062 -.434 -.190  
   S5: Anger .234 .042 .234* .043 .150 .318  
Note. β = standardized beta weight, SE = standard error, B = unstandardized beta weight, CI = 
confidence interval, R2 = coefficient of determination. 
R2 value represents the total amount of variance explained in the MCMI-II scale by the 6 factors. 
Significant unstandardized beta weights have been bolded to improve readability. 







Omega (reliability) statistics for 6-factor CBFA (53 items) 
 Total variance ECV ω ωh ωh/ω H PUC 
General factor .291 .576 .955 .848 .888 .965 .846 
S1: Somatizing .037 .074 .886 .390 .440 .800 - 
S2: Extraversion .066 .131 .644 .640 .993 .884 - 
S3: Depression .047 .092 .930 .361 .388 .783 - 
S4: Passivity .030 .060 .891 .349 .392 .685 - 
S5: Anger .034 .067 .831 .506 .609 .737 - 
(Unique) (.494) - - - - - - 
Note. ECV = Explained Common Variance index, ω = omega total, ωh = omega hierarchical, 






Item overlap between CBFA factors and MMPI-2 Restructured Clinic (RC) Scales (number of 
items) 
 RCd RC1 RC2 RC3 RC4 RC6 RC7 RC8 RC9 
General factor 1 2 1 1 0 2 3 0 3 
S1: Somatizing 1 2 1 0 0 0 0 0 2 
S2: Extraversion 0 1 0 0 0 0 0 0 2 
S3: Depression 0 0 0 0 0 1 1 0 1 
S4: Passivity 0 0 0 0 0 0 2 0 0 
S5: Anger 0 0 0 1 0 0 0 0 0 
Note. Items that loaded ≥ .30 onto the general factor (47 items) were included in the comparison 
between G and the RC scales.  
RCd = Demoralization, RC1 = Somatic Complaints, RC2 = Low Positive Emotions, RC3 = 
Cynicism, RC4 = Antisocial Behavior, RC6 = Ideas of Persecution, RC7 = Dysfunctional 





Item overlap between CBFA factors and MMPI-2 Restructured Clinic (RC) Scales (proportion of 
CBFA factor items) 
 RCd RC1 RC2 RC3 RC4 RC6 RC7 RC8 RC9 
General factor 0.02 0.04 0.02 0.02 0 0.04 0.06 0 0.06 
S1: Somatizing 0.10 0.20 0.10 0 0 0 0 0 0.20 
S2: Extraversion 0 0.10 0 0 0 0 0 0 0.20 
S3: Depression 0 0 0 0 0 0.11 0.11 0 0.11 
S4: Passivity 0 0 0 0 0 0 0.25 0 0 
S5: Anger 0 0 0 0.14 0 0 0 0 0 
Note. Items that loaded ≥ .30 onto the general factor (47 items) were included in the comparison 
between G and the RC scales.  
RCd = Demoralization, RC1 = Somatic Complaints, RC2 = Low Positive Emotions, RC3 = 
Cynicism, RC4 = Antisocial Behavior, RC6 = Ideas of Persecution, RC7 = Dysfunctional 








Figure 1. Model A, a correlated factors model; Model B, a bifactor model.   
Note. The PD Spectra scale item pool consists of 220 items; these models are for illustrative 
purposes only and therefore include only nine items.  F = factor, V = variable, E = error term, D 
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